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ABSTRACT OF DISSERTATION

AGE-RELATED ALTERATIONS IN THE DYNAMICS OF L-GLUTAMATE
REGULATION IN THE STRIATUM OF THE FISCHER 344 RAT
L-glutamate is the predominant excitatory amino acid neurotransmitter in
the mammalian central nervous system. Prior aging studies have focused
primarily on dopaminergic circuitry of the striatum, and data obtained studying
glutamate regulation in the striatum have been largely equivocal. These
discrepancies are due in large part to the limitations of microdialysis; while it is
extremely sensitive to minute concentrations of analyte, it is lacking in terms of
the temporal resolution necessary to study a neurotransmitter with rapid release
and clearance kinetics such as glutamate. In order to address this matter, our
laboratory has designed a ceramic-based multisite microelectrode with the
capability to detect and analyze fluctuations in extracellular glutamate
concentrations on a sub-second basis. These microelectrodes were utilized to
study the phasic release and uptake dynamics of potassium-evoked glutamate in
the striatum of young (6 month), late-middle aged (18 month) and aged (24
month) Fischer 344 rats. Our results showed a reduced glutamate clearance
rate and an attenuated response to potassium depolarization in the corticostriatal
projections of aged animals in comparison to other age groups. In addition,
average maximal glutamate release amplitudes were decreased in the striatum
of aged animals. Pressure ejection of exogenous glutamate solution further
confirmed the decreased glutamate clearance ability of the aged striatum. These
potassium and exogenous glutamate data also highlighted a marked
dorsoventral gradient in the striatum in terms of glutamate release and clearance
ability. We further explored this phenomenon of age-related decreased glutamate
uptake by coupling our in vivo technology with classical immunoblotting and
biotinylation techniques in order to investigate glutamate transporter regulation.
Decreased glutamate clearance in the aged rats cannot be attributed to a
reduction in steady-state total transporter protein levels. Rather, our results
indicate that reduced plasma membrane surface trafficking of GLAST in the aged
striatum may be partially responsible for this effect. Finally, we modified our
microelectrodes to study basal glutamate levels in the striatum of the aging,
freely moving rat. This approach allowed us to study extracellular glutamate

regulation free from the potential confounding variable of anesthesia. Our results
demonstrate that there is no significant alteration in basal glutamate levels in
aging in the brain regions investigated. More importantly, this study validated the
efficacy of the utilization of ceramic-based multisite microelectrodes for the study
of alterations in glutamate neurotransmission in the aging, freely moving rat, and
it lays the foundation for future work correlating such changes with ageassociated impairments in motor function.
KEYWORDS: Glutamate, Voltammetry, Aging, GLAST, Freely moving

Justin Robert Nickell
06/26/06

AGE-RELATED ALTERATIONS IN THE DYNAMICS OF L-GLUTAMATE
REGULATION IN THE STRIATUM OF THE FISCHER 344 RAT

By
Justin Robert Nickell

Greg A. Gerhardt
Director of Dissertation
Douglas Gould
Director of Graduate Studies
06/26/05

RULES FOR THE USE OF DISSERTATIONS
Unpublished dissertations submitted for the Doctor’s degree and deposited in the
University of Kentucky Library are as a rule open for inspection, but are to be
used only with due regard to the rights of the authors. Bibliographical references
may be noted, but quotations or summaries of parts may be published only with
the permission of the author, and with the usual scholarly acknowledgments.
Extensive copying or publication of the dissertation in whole or in part also
requires the consent of the Dean of the Graduate School of the University of
Kentucky.
A library that borrows this dissertation for use by its patrons is expected to secure
the signature of each user.
Name

Date

DISSERTATION

Justin Robert Nickell

The Graduate School
University of Kentucky
2006

AGE-RELATED ALTERATIONS IN THE DYNAMICS OF L-GLUTAMATE
REGULATION IN THE STRIATUM OF THE FISCHER 344 RAT

__________________________
DISSERTATION
__________________________
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy
in the College of Medicine
at the University of Kentucky

By
Justin Robert Nickell
Lexington, Kentucky
Director: Dr. Greg A. Gerhardt, Professor of Anatomy and Neurobiology
Lexington, Kentucky
2006
Copyright © Justin Robert Nickell

Dedicated to my wife Melissa, parents lynn and Robert, and precious daughter,
Rachel Morgan Nickell

ACKNOWLEDGMENTS
The pursuit of this degree has indeed led me down a long and arduous
path, although I have not traveled in solitude.

Many individuals have been

instrumental in my personal and professional development. I would like to begin
by expressing my gratitude for my mentor, Dr. Greg Gerhardt. It has been a
privilege to receive my graduate training in a laboratory that encourages
independence and strives to continually remain on the cutting edge of research.
My writing, teaching and interpersonal skills have flourished in this environment,
and I strongly believe that my growth in these areas will allow me to be very
competitive in the ever challenging world of academic research. I would also like
to thank my graduate committee, comprised of Drs. Joe Springer, Paul Glaser
and Nada Porter, for their fostering of my ideas and intellectual contribution to the
work contained in this dissertation, as well as Dr. Chris Norris for graciously
agreeing to serve in the role of outside examiner on this committee. Dr. Michael
Salvatore, Francois Pomerleau and Peter Huettl have also played a pivotal role
in my professional development that is much appreciated.
On a more personal note, I would like to thank those friends and family
members whose support has allowed me to reach this point. First and foremost,
my parents lynn and Robert Nickell deserve a special thanks for their tolerance of
what can simply be termed a "difficult" childhood, as well as for the emphasis
they placed on achieving a quality education. This sense of gratitude is also
extended to Larry and Patty Prinssen for similar reasons. Special thanks to my
wife, Melissa, and daughter Rachel Morgan for their ability to make me
remember the truly important things in life.

I would like to conclude by

acknowledging the friends that have taught me to balance school and hard work
with humor and recreation. Here's to you J.C., Matt, Michelle, Pooja, Theresa,
Kevin, Keith, Erin and Garretson.

iii

TABLE OF CONTENTS
Acknowledgments………………………………………………………………………iii
List of Tables…………………………………………………………………………....vi
List of Figures…………………………………………………………………………..vii
Chapter One: Introduction……………………………………………………………...1
Anatomy and Physiology of the Basal Ganglia…………………………………..1
The Interaction of Glutamate and Dopamine in the Striatum…………………...3
Previous Aging Research in the Striatum…………………………………….......6
Glutamatergic Neurotransmission in the Young and Aged Striatum…………..7
Glutamate Transporters: A Brief Overview……………………………………...10
Thesis Outline………………………………………………………………………11
Chapter Two: Materials and Methods…………………………………………….....16
The Fischer 344 Rat as a Powerful Model of Aging……………………...........16
Animals……………………………………………………………………………...17
Anesthetized, In vivo Amperometric Studies……………………………...........17
Microelectrode Fabrication……………………………………………………17
Microelectrode Preparation…………………………………………………...18
Microelectrode Calibration……………………………………………………19
In vivo Glutamate Measures in Anesthetized Rats………………………...19
Glutamate Release and Clearance Parameters……………………………20
Potassium-Evoked L-Glutamate Release Data Analysis……………….....21
Exogenous L-Glutamate Clearance Data Analysis………………………...21
Total Transporter Protein and Biotinylation Assays……………………...........22
Tissue Dissection and Preparation for Immunoblotting……………………22
Antibodies and Blot Immunolabeling………………………………………...23
Preparation of Crude Striatal Synaptosomes/Glial Plasmalemmal
Vesicles and Determination of Plasma Membrane-Associated EAAT…..24
Total and Membrane-Associated Protein Data Analysis…………………..25
Drugs and Reagents……………………………………………………………….25
Electrode Preparation and Calibration………………………………………25
Intracranial Pressure Ejection………………………………………………..26
Immunoblotting and Biotinylation………………………………………….....26
Chapter Three: Age-Related Changes in the Dynamics of Potassium-Evoked
L-Glutamate Release in the Striatum of Fischer 344 Rats………………………..32
Introduction…………………………………………………………………………32
Materials and Methods…………………………………………………………….34
Results………………………………………………………………………………34
Discussion…………………………………………………………………………..36

iv

Chapter Four: Reduced Plasma Membrane Surface Trafficking of GLAST
Mediates Decreased Glutamate Regulation in the Aged Striatum…………….....46
Introduction………………………………………………………………………....46
Materials and Methods…………………………………………………………….47
Results………………………………………………………………………………48
Discussion…………………………………………………………………………..51
Chapter Five: Investigations of Basal L-Glutamate Levels in the Aging
Striatum: An In vivo, Freely Moving Amperometric Study………………………...69
Introduction………………………………………………………………………....69
Materials and Methods…………………………………………………………….70
Microelectrode Design………………………………………………………...70
Microelectrode Selectivity………………………………………………….....71
Microelectrode Preparation…………………………………………………...72
Microelectrode Calibration/Recording Apparatus…………………………..72
Microelectrode Implantation…………………………………………………..73
Basal Glutamate Recording Sessions……………………………………….74
Data Analysis…………………………………………………………………..74
Results………………………………………………………………………………75
Discussion…………………………………………………………………………..76
References……………………………………………………………………………..89
VITA……………………………………………………………………………………111

v

LIST OF TABLES
Table 2.1 Distribution of Fischer 344 Rats Across Experimental Conditions……27
Table 4.5 Depth-Related Alterations in Uptake Rate as a Function of Aging…...62

vi

LIST OF FIGURES
Figure 1.1 Circuitry of the Basal Ganglia……………………………………………13
Figure 1.2 Diversity of Projections on the Medium Spiny Neuron………………..14
Figure 1.3 Typical Striatal Glutamatergic Synapse………………………………...15
Figure 2.2 Ceramic-Based Pt Microelectrode (R1 Configuration)………………..28
Figure 2.3 Anesthetized In vivo Glutamate Recording Apparatus………………..29
Figure 2.4 Extracellular L-Glutamate Signal Parameters………………………….30
Figure 2.5 Microelectrode Layer Schematic………………………………………..31
Figure 3.1 Dose-Dependency of Potassium-Evoked Glutamate Release………41
Figure 3.2 Potassium-Evoked Glutamate Uptake Rate: Representative
Tracings…………………………………………………………………………………42
Figure 3.3 Average Potassium-Evoked Glutamate Signal Parameters………....43
Figure 3.4 Depth-Related Alterations in Glutamate Uptake in Aging…………….44
Figure 3.5 Depth-Related Alterations in Corticostriatal Excitability in Aging…….45
Figure 4.1 Glutamate Uptake Rate/Amplitude Correlation………………………..57
Figure 4.2 Exogenous L-Glutamate Clearance: Representative Tracings………58
Figure 4.3 Average Exogenous Glutamate Clearance Parameters……………...59
Figure 4.4 Depth-Related Alterations in Glutamate Clearance Time (T80) in
the Striatum as a Function of Age...…………………………………………………60
Figure 4.6 Striatal L-Glutamate Transporter Protein Levels as a Function of
Age..…………………………………………………………………………………….63
Figure 4.7 Representative Biotinylation Assay……………………………………..65
Figure 4.8 Striatal Synaptosome Protein Recoveries in Plasma Membrane
(Bead Eluants) Fractions as a Function of Age...…………………………………..66
Figure 4.9 The Role of GLAST in Glutamate Dysregulation…………………..….68
Figure 5.1 Ceramic-Based Microelectrode (S2 Configuration)…………………...82
Figure 5.2 Freely Moving Microelectrode Array Preparation……………………...83
Figure 5.3 Self-Referencing S2 Microelectrode Layer Schematic………………..84
Figure 5.4 Sample Self-Referencing Microelectrode Calibration…………………85
Figure 5.5 Basal Glutamate Recordings in the F344 Striatum in Aging…………86
Figure 5.6 Time-Dependent Alterations in Basal Glutamate in Aging……………87

vii

Figure 5.7 Stress-Evoked L-Glutamate Release…………………………………...88

viii

Chapter 1: Introduction
The term "aging" refers to a complex global series of events and
processes that occur throughout the lifespan of an organism and ultimately result
in a significant impairment in normal cellular functioning. The cardinal physical
manifestations of aging related to locomotion have been well established, those
being, but not limited to, reduced motor movement velocity (bradykinesia),
stooped posture and shuffling gait (Mortimer and Webster, 1982; Teravainen and
Calne, 1983; Bennet et al., 1996). Cognitive deficits have been observed as
well, although the only consistent finding has been a marked decrease in the
short-term memory of aged animals (Carey, 2002). While these features of aging
are of a very concrete nature, the molecular and cellular changes underlying
these deteriorations are not quite as evident. For instance, while the postural
and motor impairments often observed with aging closely resemble those seen in
individuals with Parkinson's disease, researchers have failed to implicate a
substantial loss of dopaminergic neuron volume and transmitter content as being
solely responsible for these deficits (for review, see Stanford et al., 2001b).
Nonetheless, extensive aging research has been conducted in the basal ganglia,
a neural network that operates in concert with the cerebellum and motor cortex
for the initiation and progression of smooth, controlled locomotion.

Anatomy and Physiology of the Basal Ganglia
The basal ganglia are an interconnected circuit of subcortical nuclei that
collectively act to inhibit the initiation of undesired motor movements and
maintain proper posture (Fig. 1.1). An extensive review of the structures that
comprise the basal ganglia is beyond the scope of this thesis, yet a fundamental
understanding of the circuitry and its neurotransmitter components is crucial in
the analysis and discussion of the alterations of glutamate neurotransmission in
the aged striatum.
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The human striatum is located in the forebrain and is composed of two
functionally distinct regions: the caudate and putamen (dorsal striatum), which
are delineated by the fibers of the internal capsule in primates and higher
mammals, and the nucleus accumbens (ventral striatum), a pivotal structure in
the reward/motivation pathway.

Being a rich, heterogeneous environment

composed of cholinergic, dopaminergic, GABAergic, and glutamatergic axons
and cell bodies, the dorsal striatum serves as the primary input to the basal
ganglia for a wide variety of glutamatergic signals generated throughout the
cerebral cortex. These corticostriatal projections synapse on GABAergic medium
spiny neurons in close proximity to cholinergic projections from large aspiny
interneurons found in the area.
While the principle input to the striatum is glutamatergic in nature, another
key component of the basal ganglia projects dopaminergic fibers to this region.
The substantia nigra (SN) is located in the midbrain, and is also differentiated
into two segments.

The substantia nigra pars reticulata (SNpr) receives

inhibitory input from the striatum, as well as excitatory information from the
subthalamic nucleus (STN), and plays a prominent role in eye movements. The
other subdivision of this region, the substantia nigra pars compacta (SNpc), is
perhaps the most intensely researched component of the basal ganglia due to
the finding that degeneration of this region is the prominent pathology in the
brains of those afflicted with Parkinson's disease. This densely cellular region
provides the primary dopaminergic input to the striatum and forms synapses in
close proximity to corticostriatal projections on the medium spiny neuron. This
juxtaposition of dopamine and glutamate allows for extensive interaction of these
neurotransmitters and thus synaptic modulation at the level of the dendritic
spines.
Signals processed in the striatum progress through the basal ganglia in
one of two pathways depending on which variety of medium spiny neuron is
stimulated.

These

neurons,

while

morphologically

homogenous,

are

heterogeneous in terms of peptide neurotransmitters and the other molecules
they contain, and therefore may be characterized into two distinct populations.
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Medium spiny neurons with dendritic spines that house D1 class receptors
contain dynorphin and substance P, and stimulate adenylate cyclase upon
binding of dopamine.

The peptide neurotransmitters found in the remaining

neurons are enkephalin, and their D2 receptors serve an inhibitory role upon
activation by dopamine.
Following stimulation of D1-containing neurons, GABAergic tone to the
internal segment of the globus pallidus (GPi) and SNpr is increased, which leads
to decreased GABAergic tone in the ventral lateral nucleus of the thalamus. The
thalamus then increases glutamatergic tone to the motor cortex, thus influencing
motor movement. Because of the non-circuitous nature of this route, it is termed
the "direct", or striatonigral, pathway. Signals processed via the striatopallidal, or
"indirect", pathway follow a much more complex route. Binding at D2 receptors
inhibits GABA release in the external segment of the globus pallidus (GPe),
which increases GABAergic tone at the subthalamic nucleus (STN).

This

inhibitory action on the STN reduces glutamate neurotransmission at the
GPi/SNpr, reducing GABAergic tone in the ventral lateral thalamus leading to an
overall increased glutamatergic tone in the motor cortex.

The Interaction of Glutamate and Dopamine in the Striatum
As previously mentioned, the dendrites of the medium spiny neuron are a
juncture for the variety of neurotransmitters present in the striatum (Fig. 1.2).
While the projections containing these transmitters may all synapse on a
common dendrite, glutamate and dopamine projections often synapse in much
closer proximity to one another; a large percentage of these projections have
been discovered to share dendritic spines (Bouyer et al., 1984; Freund et al.,
1984).

As a result, glutamate/dopamine interplay is crucial in modulating

information relayed from the cerebral cortex. Researchers have postulated for
well over a decade that pharmacological intervention at this juncture could act as
a feasible means of treatment of the motor abnormalities and deficiencies
observed in patients with motor-related disorders such as Parkinson's disease.
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Therefore, it should come as no surprise that many groups have extensively
investigated corticostriatal glutamatergic control over dopamine release.
In vitro experiments conducted in rat striatal brain slices have
demonstrated a concentration-dependent increase in extracellular dopamine
levels following the administration of glutamate (Giorguieff et al., 1977; Roberts
and Sharif, 1978), a phenomenon that is blocked upon the application of the
glutamate receptor antagonist glutamic acid diethlyester (Roberts and Anderson,
1979).

In vivo push-pull methodology has been used as well to study this

phenomenon.

Nieoullon et al. (1978) showed an increased concentration of

dopamine in the striatum following electrical stimulation of the motor and visual
areas of the feline cerebral cortex.
Following these discoveries, scientists strove to uncover the cellular
mechanisms responsible for glutamate's facilitation of dopamine release in the
striatum.

The actions of synaptic glutamate are mediated by a number of

receptors located both pre- and post-synaptically. Three classes of ionotropic
glutamate receptors have been characterized based on their affinities for specific
agonists: N-methyl-D-aspartate (NMDA), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainic acid.

Metabotropic glutamate receptors

(mGluRs) are another family of receptors coupled to intracellular second
messenger systems via G proteins, and consist of two classes.

mGluR1

receptors (mGluR1, mGluR5) activate phospholipase C and adenylate cyclase,
ultimately facilitating neurotransmitter release.

The remaining mGluRs inhibit

neurotransmitter release by inhibiting cAMP production, thus making this
subclass of receptor a key member of the presynaptic mechanism responsible for
maintaining low levels of extracellular transmitter in instances of excessive
glutamate overflow.
An overwhelming majority of prior studies have focused on the NMDA
receptor's role in stimulating dopamine release. Low concentration infusions of
NMDA into the rat striatum strongly stimulate dopamine release, an effect that is
tetrodotoxin (TTX)-dependent (Morari et al., 1993). Likewise, this effect was also
observed in the striatum of freely moving rats (Westerink et al., 1992), and
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electrophysiological studies also support the notion that NMDA receptors play a
key role in facilitating dopamine release (Overton and Clark, 1991). Collectively,
these data have led researchers to postulate that glutamate exerts its influence
on dopamine release by binding to NMDA receptors present on the terminals of
nigrostriatal afferents. Similar results have been obtained following applications
of AMPA (Desce et al., 1992; Wang, 1991) and kainate (Jin and Fredholm, 1994)
receptor agonists and antagonists, and the behavioral effects of mGluR
manipulation suggest glutamate receptor-mediated dopamine release (Sacaan et
al., 1992), but the data available for these receptor classes is relatively scarce in
comparison to those collected in studies of the NMDA receptor.
The effects of dopamine on glutamate release have been intensively
researched as well. While glutamate acts to stimulate the release of dopamine at
the level of the medium spiny neuron dendrite, an elevation of extracellular
dopamine corresponds with an inhibition of glutamate release. This has been
demonstrated in many in vivo studies, as stimulation of the ventral tegmental
area of the midbrain, dopamine iontophoresis, and the administration of
dopaminergic drugs all resulted in a reduction of stimulus-evoked excitatory
responses from corticostriatal afferents (Pennartz et al., 1994; Floresco et al.,
2001; Yang and Mogenson, 1984). In addition, the application of dopamine or D2
receptor agonists to the bath medium of striatal brain slices resulted in a
reduction of the amplitude of excitatory postsynaptic potentials (EPSPs) evoked
by the electrical stimulation of corticostriatal pathways (O'Donnell and Grace,
1994; Hsu et al., 1995; Levine et al., 1996).
Substantial evidence has accumulated to identify the D2 receptor as being
primarily responsible for mediating these effects.

A neuroanatomical study

localized these receptors to corticostriatal afferents originating in the prefrontal
cortex (Wang and Pickel, 2002), and the medium spiny neurons of mice with a
deficiency of these receptors exhibit larger amplitude depolarizations and an
increased frequency of spontaneous activity in comparison to wild type mice
(Cepada et al., 2001).

Collectively, these findings indicate that release of
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dopamine from nigrostriatal afferents inhibits glutamate release in the striatum
via a presynaptic D2-receptor mediated mechanism on corticostriatal projections.
Previous Aging Research in the Striatum
A

thorough

understanding

of

the

interaction

between

these

neurotransmitters in the striatum is critical in researching alterations in glutamate
neurotransmission for several reasons, the foremost being that a preponderance
of prior aging studies in the basal ganglia have been conducted in dopamine
circuitry, in particular the nigrostriatal pathway. It has been widely known for
nearly half of a century that the SNpc of those individuals afflicted with
Parkinson's disease lacked dopamine (Ehringer and Hornykiewicz, 1960), and
that the administration of the dopamine precursor L-dopa was effective at
alleviating the motor abnormalities associated with this disease (Cotzias et al.,
1967, 1969).

Because many of the symptoms of Parkinson's disease

(bradykinesia, shuffling gait) closely resemble the declines in motor function
observed in aged individuals, the nigrostriatal circuitry became a popular target of
research for those studying both Parkinson's disease and aging.
As a result, a literature search for alterations in dopamine transmission in
aging yields a plethora of research relating to many aspects of cellular and
molecular dopamine neuron functioning. A previous widespread tenet of aging
has been that age-related motoric abnormalities are due in large part to a
reduction in the number of dopamine neurons. While normal, non-pathological
aging is accompanied with an approximate 50% reduction in tyrosine
hydroxylase-immunoreactive neuron number, it has become apparent that cell
loss alone cannot exclusively account for these deficiencies (West and
Gundersen, 1990; West, 1993; West et al., 1994; Emborg et al., 1998). Rather,
these motoric declines are most likely due to a combination of a number of agerelated factors, including, but not limited to, reduced dopamine release and
clearance, increased threshold for elicited electrophysiological responses, and
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decreased dendritic branch volumes of medium spiny neurons (for review, see
Stanford et al., 2001b).

Glutamatergic Neurotransmission in the Young and Aged Striatum
Due to the extensive interaction between dopamine and glutamate and the
well-documented alterations that occur in the dopamine circuitry in aging, it is
only natural to assume that similar changes occur in the glutamatergic
corticostriatal projections. Unfortunately, minimal data are available pertaining to
this subject. The pathway of glutamate release, clearance, and metabolism in
the young, healthy striatum, however, has been extensively studied (Fig. 1.3).
Depolarization of corticostriatal projections results in the influx of calcium ions in
the axon terminals, which in turn stimulate the binding of vesicular glutamate
transporters (VGLUTs) to the presynaptic terminal membrane and the
subsequent release of glutamate into the extracellular space. Glutamate freely
diffuses to the postsynaptic medium spiny neuron dendrite, at which point it binds
to AMPA and NMDA receptors and induces the influx of sodium and calcium ions
into the neuron.
The clearance of glutamate from the synapse is performed exclusively by
a series of high-affinity, sodium-dependent excitatory amino acid transporters
(EAATs).

This process is robust and rapid, as glutamate poses a severe

excitotoxic threat to surrounding neurons if conditions arise that facilitate
accumulation of the neurotransmitter in the extracellular space (Olney, 1969).
The two transporters responsible for >90% of glutamate clearance, glutamate
transporter (GLT-1) and glutamate-aspartate transporter (GLAST), are localized
to neuroglia, while the remaining ~10% of glutamate is removed by the excitatory
amino acid transporter (EAAC) located on the postsynaptic membrane of the
medium spiny neuron. The process of glutamate clearance takes advantage of
the ion gradient established to drive neuron depolarization and so is extremely
energetically favorable; co-transported with glutamate are three sodium ions and
a proton, while a potassium ion is transported extracellularly (for review, see
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Danbolt, 2001). For a more thorough discussion of these transporters and their
regulation, please see below and Chapter Four. Once segregated in the glia,
glutamate is metabolized to glutamine by the glial enzyme glutamine synthetase
and returned to the corticostriatal neuron.

The mitochondrial enzyme

glutaminase then converts glutamine to glutamate which is to be packaged inside
VGLUTs.
The aspects of this pathway have been studied in the context of aging,
yet, as already mentioned, the data are scarce. Further complicating matters,
the data that have been collected are equivocal to a large extent.

Total

glutamate content is a parameter that has been studied in a number of brain
regions.

Some researchers discovered a modest (10-20%) decrease in total

glutamate levels (Price et al., 1981; Strolin-Benedetti et al., 1990, 1991), while
others showed an apparent consistency of glutamate concentration in the
striatum throughout aging (Saransaari and Oja, 1995; Wallace and Dawson,
1990). It must be noted that the striatum is a very heterogeneous structure (see
Chapters Three and Four), suggesting that the obvious inconsistencies of these
results may be due in large part to varying densities of corticostriatal projections
in the different regions. In order to address this issue, Donzanti and Ung (1990)
conducted a series of experiments in which the goal was to differentiate eight
regions of the striatum based upon their total glutamate content. The results
ranged from a significant increase in glutamate content of 40% in the aged
anterior dorsolateral striatum to no alterations in regions such as the posterior
dorsomedial striatum, yet in no regions was there a decrease in glutamate
content as was indicated in studies by other groups.
The sensitivity of glutamate fibers is another area of interest for those
studying aging in the striatum. Glutamate release can be investigated both in
vivo as well as in vitro through the usage of two different models; push-pull
microdialysis allows for sampling of extracellular neurotransmitters following
chemical stimulation, while brain slice and synaptosome preparations afford the
investigator ease of use to analyze the content of glutamate in the superfusion
medium.

Once again, the results are equivocal.
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Two groups found a large

decrease in the concentration of potassium-evoked glutamate in the aged
striatum (Freeman and Gibson, 1987; Saransaari and Oja, 1995), while another
found no change in the ability of the aged striatum to release glutamate despite
the injection of a higher concentration of potassium (Corsi et al., 1997, 1999). In
terms of basal glutamate release in aging, some researchers showed an
astounding

77-190%

increase

in

non-stimulated

extracellular

glutamate

(Freeman and Gibson, 1987; Massieu and Tapia, 1997), others indicated a
decrease in glutamate levels (Corsi et al., 1997), and yet others found no change
in basal levels (Saransaari and Oja, 1995; Porras and Mora, 1995; Corsi et al.,
1999).
The collective results that pertain to glutamate clearance in the aged
striatum are inconclusive as well. Price et al. (1981) and Najerahim et al. (1990)
both discovered a curious decrease in uptake rate in middle-aged rats that was
restored in the striatum of the aged animals. A single investigator showed a
significant increase in uptake rate in the aged rats, while others found no
difference in glutamate clearance rates in aging (Palmer et al., 1994; Strong et
al., 1984). Taken together, these data make it difficult to definitively determine
the nature of glutamate regulation in the aged rat striatum (refer to Chapter Three
for discussion).
One finding that is without such contention concerns alterations in
glutamate receptor density in aged animals.

NMDA receptor density in the

striatum has been consistently reported to be moderately reduced (20-50%) in
aged rats, regardless of the method used to assay for such a change (Cimino et
al., 1993; Castorina et al., 1994; Wenk et al. 1991). In addition, a concurrent
marked decrease in NMDA receptor mediated response has been observed
(Cepeda et al., 1996). A single study found that no change in AMPA receptor
density occurs in the aged rat striatum (Cimino et al., 1993), and no aging
research has been conducted to determine if there are alterations of mGluR
density in this region.
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Glutamate Transporters: A Brief Overview
The process of termination of glutamate neurotransmission is quite
different from the clearance and metabolic mechanisms observed in other
neurotransmitter systems. There have been no synaptic enzymes identified to
date that degrade extracellular glutamate to a significant degree, and while the
presence of a presynaptic glutamate transporter remains plausible, all available
evidence for such a transporter appear to have been collected using
questionable experimental design (for review, see Danbolt, 2001). This has led
researchers to formulate and accept the general conclusion that glutamate is
cleared from the synapse almost exclusively via an efficient system of
transporters localized to the glia and postsynaptic neuron membrane surfaces.
The common molecular structure of these transporters has historically
been a topic of debate. The initial publications (Kanai and Hediger, 1992; Pines
et al., 1992; Storck et al., 1992) describing the discovery of these transporters in
the last decade postulated that their structures consist of either six, eight or ten
putative transmembrane spanning domains (TM).

Hydropathy plots have

confirmed that each transporter indeed possesses at least six TMs (Kanai et al.,
1993) with an extended extracellular sequence of amino acids between TM3 and
TM4 (Slotboom et al., 1996; Grunewald et al., 1998; Seal and Amara, 1998) that
is a site for transporter glycosylation (for review see Seal and Amara, 1999).
Also without contention is the finding that both the carboxy and amino termini are
intracellular (Lehre et al., 1995; Danbolt et al., 1998; Dehnes et al., 1998).
Further work in this area has since shifted the consensus opinion to these
transporters having eight TMs (for reviews see Danbolt, 2001; Slotboom et al.,
1999).

This understanding of the conserved nature of these transporters is

necessary when interpreting data pertaining to the regulation of glutamate
clearance in the aged striatum (Chapter Four).
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Thesis Outline
As evidenced by this discussion of alterations of glutamatergic
neurotransmission in the aged rat striatum, there is much remaining to be done.
The work presented herein serves to expand upon the foundation of the
regulation of glutamate release and clearance in aging. In Chapter 3, we used a
multisite ceramic-based microelectrode for rapid and low level measures of
glutamate in vivo. We measured the amplitude and clearance rate of phasic
changes in glutamate release produced by local application of potassium by a
micropipette placed adjacent to the recording sites in the striatum of anesthetized
young (6 month), late-middle aged (18 month) and aged (24 month) Fischer 344
(F344) rats.

Our results show that the amplitudes and clearance rates of

potassium-evoked release of glutamate in the striatum are significantly
decreased in aged rats as compared to the other age groups. In addition, the
sensitivity of glutamate fibers to depolarization with potassium was significantly
decreased in the aged rats. Taken together, these data are consistent with agerelated alterations in glutamate release dynamics, which may involve a
compensatory mechanism for maintaining static glutamate concentrations within
the striatum.
Chapter 4 further explores the potential molecular underpinnings of this
reduced glutamate clearance ability. Extracellular L-glutamate poses a severe
excitotoxic threat to neurons and glia when unregulated, therefore low synaptic
levels of this neurotransmitter must be maintained via a rapid and robust
transport system. The included study utilized in vivo electrochemical recordings,
immunoblotting and biotinylation in young, late-middle aged and aged F344 rats
to elucidate the potential role that glutamate transporters (GLT-1, GLAST, and
EAAC1) may play in this mechanism. We found that the decreased glutamate
clearance efficiency is not due to a decrease in the production of total transporter
protein among these three transporters. Rather, a significant reduction in the
amount of GLAST trafficked to the plasma membrane surface in the aged
animals (~55% when compared to young rats) may be partially responsible for
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this phenomenon.

These age-related alterations in extracellular L-glutamate

regulation may be key contributors to the increased susceptibility of the aged
brain to excitotoxic insults such as stroke and hypoxia, and may also play a role
in age-associated motoric decline.
Chapter 5 chronicles the development of in vivo, freely moving
voltammetric recordings as a tool in studying the aging of glutamatergic
neurotransmission in the rat striatum.

This technology is a significant

improvement over the anesthetized electrochemical recording preparations, as it
affords us the opportunity to study glutamate release and uptake dynamics free
from the influence of anesthetic, and also allows us to study the temporal
dynamics of neurotransmitter regulation while an animal performs a behavioral
task. Data obtained from these experiments indicate moderate but insignificant
changes in basal glutamate levels throughout aging. This preliminary research
will be pivotal in the design of future aging studies attempting to correlate agerelated motor dysfunction with altered glutamate neurotransmission in the
striatum.
Copyright © Justin Robert Nickell 2006
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Adapted from Bar-Gad and Bergman (2001)

Figure 1.1 Circuitry of the Basal Ganglia
Schematic illustrating the principle projections to the striatum and their various
neurotransmitter components.

Checkerboard pattern represents dopamine

projections, black arrows denote glutamate projections, and grey represents
GABA projections; squares denote inhibition, while arrows represent neuron
stimulation. Please see text for an extensive discussion of these pathways.
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Figure 1.2 Diversity of Projections on the Medium Spiny Neuron
Cholinergic projections from interneurons synapse on dendritic shafts, while
GABAergic projections from neighboring medium spiny neurons synapse directly
on the neuron cell body.

Corticostriatal glutamatergic and nigrostriatal

dopaminergic afferents synapse on common dendritic spines.

The close

proximity of these terminals allows for direct modulation of presynaptic
neurotransmitter release, a phenomenon which may play a prominent role in
age-related motor dysfunction.
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Figure 1.3 Typical Striatal Glutamatergic Synapse
Following its release, glutamate binds to AMPA, NMDA and mGluR receptors
located postsynaptically to influence ion influx and subsequent EPSP generation.
Glutamate neurotransmission is terminated exclusively via the high-affinity
sodium dependent transporters (GLAST, GLT-1 and EAAC1) present primarily
on the glial cell membrane and to a lesser extent on the postsynaptic membrane.
Presynaptic mGluR's act as autoreceptors to diminish glutamate release in the
event of excessive spillover.

At right is a magnified view of a standard

transporter and the specific stoichiometry of the glutamate clearance process.
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Chapter Two: Materials and Methods

The F344 Rat as a Powerful Model of Aging
Aging is a multifaceted process that affects all aspects of the mammalian
central nervous system at differing rates and to varying degrees. Therefore, an
appropriate animal model must be selected that demonstrates many of the
physical and cellular manifestations observed in aged humans.

The rodent,

specifically C57BL mice, Sprague-Dawley, Wistar, and the F344 rat, has
traditionally been the model of choice for studying the aging of the nigrostriatal
circuitry (Austad, 1997), as they exhibit marked age-related motor deficits. The
F344 strain of rat has an inherent advantage over other rodent strains in that it is
inbred. This high degree of genetic constraint limits the possibility that any of the
alterations we observe in the aging of these animals are due to substantial
genetic variation.

In other words, any increases in life longevity and quality

amongst animals will be limited, as genetic "superiority" will not be a confounding
factor in these experiments.

In addition, the body weight of these animals

remains relatively consistent throughout their lifespan, limiting any maturationdependent alterations in brain volume (Masoro, 1990).
Researchers agree that there is slight variability in lifespan amongst the
various rat strains utilized for studying aging (Masoro, 1990; Sprott and Austad,
1996), yet a consensus has been reached as to when to classify a rat as "aged".
All rat strains, including the F344 rat, are deemed aged upon reaching 22 months
of age. With this in mind, three age groups were selected for the study of agerelated alterations in glutamatergic transmission in the striatum: young (6 month),
late-middle aged (18 months), and aged (24 months).

These age groups

approximately simulate humans of the ages of 18, 54, and 72 years, respectively.
The addition of the late-middle aged F344 rats circumvents the confounding
variable of differential maturation processes, as studies concerning aging should
always be conducted in more than two age groups (Coleman and Flood, 1987).
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Animals
Young adult (6 months, n = 31), late-middle aged (18 months, n = 28), and
aged (24 months, n = 30) male F344 rats were obtained from the National
Institute on Aging (Harlan Sprague Dawley, Inc., Indianapolis, IN) and used for all
experiments.

Please refer to Table 2.1 for distribution of animals across

experiments. Protocols for animal use were approved by the Institutional Animal
Care and Use Committee.

Animals were housed according to approved

guidelines, with food and water available ad libitum.

Anesthetized, In vivo Amperometric Studies

Microelectrode Fabrication
Ceramic-based

multisite

microelectrodes

are

mass

conjunction with Thin Films Technology, Inc. (Buellton, CA).

produced

in

The fabrication

process consists of a series of photolithographic techniques that have several
distinct advantages over the various other methods used to fabricate
microelectrodes.

Photolithography allows routine production of reproducible

recording surfaces as small as 5-10 µm. In addition, multiple microelectrodes are
patterned onto a single fabrication substrate (2.5 cm x 2.5 cm), allowing for
increased fabrication number at a decreased cost.

Finally, photolithographic

methods are used to manufacture numerous microelectrode designs with
multiple recording sites in well-defined, highly reproducible geometrical
configurations (for review, see Hascup et al., 2006).
The particular recording site geometrical configuration selected for the
anesthetized electrochemical recordings was the R1 configuration (Fig. 2.2).
This configuration consists of an in-line alignment of four recording sites with 50
µm spacing between sites. Individual recording sites possess the dimensions of
50 x 150 µm. This configuration provides a larger recording distance that is
useful in the study of larger brain regions or layered structures, such as the
striatum.
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Microelectrode Preparation
The ceramic-based microelectrode arrays with platinum (Pt) recording
surfaces were fabricated, assembled and selected for in vivo recordings using
our previously published methods (Burmeister et al., 2000, 2002) (Fig. 2.5).
Microarrays were first coated with Nafion (Sigma-Aldrich, St. Louis, MI) to
enhance their selectivity in vivo for glutamate versus ascorbic acid or other
anionic interferents (Gerhardt et al., 1984).

Fresh stock Nafion solution was

placed in a 1.5 ml Eppendorf tube and allowed to thicken to room temperature for
1 hour in a humidity-controlled dessicator.

The microelectrode tip was then

lowered into the Nafion and rotated gently for approximately five seconds prior to
being oven baked at 175°C for four minutes to remove any traces of humidity and
to dry the Nafion film. We have found that this procedure is optimal for attaining
a desired selectivity of > 100:1 for ascorbate based on a calculated slope of at
least 5 pA/micromolar glutamate.

Additional Nafion coatings resulted in a

reduced glutamate sensitivity due to H2O2's inability to traverse a thicker layer of
anion repellent, while the application of a thinner coat of Nafion led to a
substantial increase in levels of background ascorbic acid in the striatum upon
solution application (Burmeister et al., 2002).
Microelectrodes were then coated with L-glutamate oxidase to make them
sensitive to glutamate in vivo. A 10 µl solution consisting of 1% BSA, 0.125%
glutaraldehyde, and 1% glutamate oxidase was prepared, and then applied to the
Pt recording sites beneath a dissecting microscope. A small drop of the enzyme
solution (~0.10 µl) was suspended from a pipette tip and placed on the sensor
site for 1-2 seconds. If successfully applied, a thin, luminescent layer of protein
was observed on the sensor sites when viewed under a dissecting microscope.
To ensure that an adequate layer of enzyme was applied to the recording sites,
and because we have observed that increasing layer thickness does not
correspond to a decrease in glutamate sensitivity, two additional coats of enzyme
were applied in the same manner. Microelectrodes were then stored in a lowhumidity environment for at least two days to allow for optimal enzyme layer
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curing time. Please refer to Chapter Three for further discussion of the necessity
of these layers.

Microelectrode Calibration
Constant voltage amperometry was performed using a FAST-16 highspeed electrochemistry instrument (Quanteon, L.L.C.) using software (Fast
Analytical

Sensor

Technology)

designed

for

simultaneous

four-channel

recordings. An Ag/AgCl reference electrode was placed in a continuously stirred
solution of 0.05 M PBS (37°C, pH 7.4) in conjunction with the microelectrode
operated at an applied potential of +0.7 V vs. Ag/AgCl reference electrode. A
recirculating water bath (Gaymar Co.) was utilized to maintain a constant buffer
temperature of 37°C. Amplifiers were adjusted to obtain a final gain of 200 pA/V
for all recordings.

Calibrations were performed by achieving final buffer

concentrations of 250 µM ascorbic acid and 10, 20, 30, and 40 µM L-glutamate
through additions of aliquots of 20 mM ascorbic acid and 20 mM L-glutamate
stock solutions.

Selectivity ratios for glutamate over ascorbic acid were

calculated as well as the slope (sensitivity), limit of detection (LOD), and linearity
(R2) for glutamate.

In Vivo Glutamate Measures in Anesthetized Rats
Electrode/micropipette assemblies used for the in vivo recordings
consisted of a ceramic-based working electrode and a single-barrel (1 mm o.d.,
0.58 mm i.d. glass, A-M Systems, Inc., Everett, WA) micropipette. The tips of the
micropipettes had inner diameters of 10-15 µm, and were positioned 100 + µm
between recording sites two and three of the microelectrode arrays. They were
attached to the printed circuit board holder of the ceramic-based multisite
microelectrode using Sticky Wax (Kerr Brand).
Male F344 rats were anesthetized with urethane (1.25g/kg, i.p.) and
placed within a stereotaxic frame for the performance of a craniotomy. A three
cm sagittal incision was made on the skin of the cranium, and underlying fascia
was displaced with a cotton swab.

Bulldog clips were applied to limit the
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movement of the skin while performing this procedure. Using a common Dremel
tool, a 2 mm x 2 mm square section of the skull cap was removed in the upper
right quadrant relative to bregma and the sagittal suture. Underlying dura was
carefully excised with the aid of forceps. A miniature (200 µm diameter) Ag/AgCl
reference electrode was implanted into a site that was remote from the recording
area to prevent drifting of the working electrode potential. A KCl (70 mM KCl, 79
mM NaCl, 2.5 mM CaCl2, pH 7.4; Chapter Three) or glutamate solution (5 mM Lglutamate, pH 7.4; Chapter Four) was loaded into a single-barrel micropipette.
The potassium solution was used to study phasic release of glutamate as
described in Chapter 3, while the glutamate solution was used in Chapter 4 to
determine

the

temporal

dynamics

of

glutamate

uptake.

The

microelectrode/micropipette array was inserted into the striatum (AP +1.0 mm,
ML -2.5 mm, DV -3.0 to -7.0 mm) of the rat brain; coordinates were calculated
from bregma based on the rat brain atlas of Paxinos and Watson (1986).
Volumes of KCl and glutamate solution were pressure-ejected from the
micropipettes using a Picospritzer II (Parker Hannifin Corp., General valve
operation) and monitored using a stereomicroscope fitted with a reticule
(Friedemann and Gerhardt, 1992) (Fig. 2.3). The FAST-16 recording system
(Quanteon, L.L.C.) was used to record the resulting L-glutamate signals at the
multisite microelectrodes. Animals were euthanized at the conclusion of each
recording session via an overdose of anesthetic.

Glutamate Release and Clearance Parameters
Chemical stimulation or the application of exogenous glutamate solution
produces a glutamate signal with a very distinct graphical "fingerprint". Figure
2.4 illustrates the typical spike-shaped appearance of a glutamate signal that is
representative of the fluctuation of extracellular glutamate concentration as a
function of time. Amplitude (µM) is simply a measure of the maximal extracellular
L-glutamate concentration achieved following its evoked-release or application,
while rise time (TR, sec) describes the time necessary to achieve this amplitude
from onset of the origin of the signal. TTotal indicates the time necessary for
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glutamate levels to return to baseline and encompasses the entire duration of the
signal.
Several other parameters exist that are useful in describing the clearance
characteristics of the generated glutamate signals.

T50, T80, and T100 (sec)

indicate the amount of time necessary to decay 50, 80, and 100 percent of the
signal from onset of maximum amplitude. K-1 (sec-1) is a decay rate constant
(first exponential rate of fit) and is independent of signal amplitude. This value is
representative of the slope of the linear regression of the natural log
transformation of these data over time. Finally, uptake rate (µM/sec) is obtained
by multiplying the K-1 rate constant by the maximum amplitude of the signal.
Potassium-Evoked L-Glutamate Release Data Analysis
Dose-response studies were conducted in each striatal recording site to
determine the maximum potassium-evoked glutamate responses in the young,
late-middle aged, and aged rats (young rats, n = 182; late-middle aged rats, n =
304; old rats, n = 82). Only signals ranging from 10-20 µM in amplitude were
selected for analysis of the temporal properties of the release signals, as
glutamate signals within this range were the highest that were consistently
attainable in the aged animals. Approximately 20 signals were obtained from
each depth in the striatum (ventral positions -3.0 to -7.0 mm in 0.5 mm
increments). This resulted in a large total number of signals collected from the
young (n = 401), late-middle aged (n = 318) and aged (n = 279) rats for the
temporal analyses of the glutamate signals. Data were analyzed using a one
way analysis of variance followed by Tukey's post hoc comparisons. Statistical
significance was defined as p<0.05.

Exogenous L-Glutamate Clearance Data Analysis
Only signals ranging from 10-20 and 20-40 µM in amplitude were selected
for analysis of the temporal properties of glutamate uptake, as uptake rate was
discovered to increase as amplitude does the same (see Chapter Four for further
discussion). Approximately 20 signals were obtained from each depth in the
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striatum (ventral positions -3.0 to -7.0 mm in 0.5 mm increments). This resulted
in a large total number of signals collected from the young (n = 1092), late-middle
aged (n = 415) and aged (n = 838) rats for the temporal analyses of the Lglutamate signals. Because the number of data points obtained varies across
animals, a nested between-groups analysis of variance (ANOVA), using
SYSTAT's Multivariate General Linear Model (SYSTAT Software, Richmond, CA,
USA), was used to separate potential variance resulting from individual
differences in sample number from the main effects for experimental groups.
Making an assumption that each data point represents an individual animal
would be pseudoreplication, which artificially inflates degrees of freedom
(Hurlbert, 1984). The use of the nested between-groups ANOVA test does not
assume that each data point was taken from an individual animal. A categorical
variable was included that labeled each data point according to the individual
animal from which it was obtained. By taking this approach, main effects for age
groups were independent of variance due to differences in the numbers of
samples per animal.

Analyses were followed by Tukey's post-hoc tests if

statistical significance was evident from the omnibus F test.

Statistical

significance was defined as p< 0.05.

Total Transporter Protein and Biotinylation Assays

Tissue Dissection and Preparation for Immunoblotting
All animals were decapitated under urethane (1.25 g/kg, i.p.) anesthetic,
and their brains rapidly removed and dissected in 1 mm coronal slices using a
chilled rodent brain matrix. The dorsal striatum was extracted from three or four
slices using a 14-gauge needle, and the tissue was frozen at -70 ºC. Frozen
tissue samples were sonicated in 300 µl 1% sodium dodecyl sulfate solution (pH
~8) using a Fisher 60 sonic Dismembrator. Protein concentrations of the tissue
samples were determined using the bichinchoninic acid method (BCA), and
appropriate volumes of sample buffer were administered to achieve a final
protein concentration of 2 µg/µl in each sample.
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Following electrophoresis,

sample proteins were transferred overnight in Tris/glycine/methanol buffer onto
nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA). The blots were
then placed in Ponceau stain to visualize and verify approximate protein loads,
followed by a 1 hr. immersion in quenching buffer (a buffer that reduces nonspecific binding of the antibodies to protein) containing 1% polyvinylpyrrolidone
and 0.05% Tween 20 for a minimum of 1 hr. After a 1 hr. incubation in primary
antibody, blots were incubated in appropriate secondary antibody (swine antirabbit IgG (0.8 µg/ml) or rabbit anti-mouse IgG (1 µg/ml; Dako, Glostrup,
Denmark) for 1 hr., followed by a 1 hr. incubation with [125I] protein A (specific
activity 1.3 GBq/mg; Amersham, Piscataway, NJ).

Antibodies and Blot Immunolabeling
A guinea pig polyclonal antibody targeting the carboxy-terminus of GLT-1
was purchased from Chemicon International (cat. # AB1783) and used at a
dilution of 1 µg/ml.

A rabbit polyclonal antibody raised against the carboxy-

terminus of GLAST was purchased from Novus Biologicals (cat. # ab416) and
used at a dilution of 1 µg/ml. A monoclonal antibody targeting the carboxyterminus of EAAC1 was obtained from Chemicon International (cat. # MAB1587)
and used at a dilution of 2 µg/ml. These antibodies were used to assay both total
transporter protein levels as well as plasma membrane-associated protein levels,
and the amount of protein loaded to assay total levels of transporter (30 µg for
GLT-1, 15 µg for GLAST, and 60 µg for EAAC1) was well within the linear
working range of each particular antibody.
Quantification of total and plasma membrane-associated EAAT protein
levels was carried out via autoradiography.

Immunoreactive portions

corresponding to the protein of interest on the blots were detected, and these
areas were excised and gamma radioactivity measured for each sample. Please
see Results in Chapter Four for an extensive discussion of biotinylation data and
analysis.
In the EAAT plasma membrane expression study, plasma membraneassociated EAAT was defined as EAAT-immunoreactivity (EAAT-IR) from Lamelli
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Buffer eluant collected from avidin beads and normalized to EAAT-IR in the
lysate (which represents total EAAT-IR present prior to avidin bead addition) in
each sample.

Preparation of Crude Striatal Synapotosomes/Glial Plasmalemmal
Vesicles and Determination of Plasma Membrane-Associated EAAT
We assessed the plasma membrane content of EAAT in crude striatal
synaptosomes/glial plasmalemmal vesicle preparations using the membrane
impermeant biotinylating reagent, sulfosuccinimidobiotin (NHS-biotin).

This

method has been previously established for studies of protein plasma membrane
expression of DAT in these preparations (Salvatore et al., 2003; Zhu et al. 2005).
Striatal tissue was homogenized in ice-cold 0.32 M sucrose and spun at 1000 x g
for 10 min. The resulting supernatant was spun at 12, 500 x g for 15 min. and
the pellet containing the crude synaptosomes was suspended in Krebs
bicarbonate buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 25 mM
NaHCO3, Na2EDTA, 1.7 mM CaCl2, 10 mM glucose, 100 µM paraglyine, 100 µM
ascorbic acid; bubbled with 95:5 O2:CO2). 500 µg total protein aliquoted from
these preparations for each age group was incubated for 1 hr. at 4 ºC (a
temperature that arrests endocytosis) in 500 µl of 1.5 mg/ml NHS-biotin in
PBS/Ca/Mg buffer (138 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 9.6 mM
Na2HPO4, 1 mM MgCl2, 0.1 mM CaCl2, pH 7.3).

Biotinylating agents were

removed by twice rinsing the pellet formed, followed by a 30-min. incubation with
ice-cold 100 mM glycine in PBS/Ca/Mg buffer. Preparations were further washed
three times with PBS/Ca/Mg buffer and then lysed in 300 µl Triton X-100 buffer
(10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) containing
protease inhibitors (1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µM pepstatin, 250 µM
PMSF). Aliquots of these Triton-sonicated lysates were taken for subsequent
normalization of total EAAT against the biotinylated fraction and the remaining
lysate was centrifuged for 20 min. at 20,000 x g at 4 ºC to remove nuclear
components.

The supernatants were then incubated with monomeric avidin

beads (100 µl/tube) in the same buffer for 1 hr. at room temperature. The beads
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were then washed in Triton X-100 buffer and the adsorbed biotinylated proteins
were eluted by incubating in Lamelli buffer (62.5 mM Tris, pH 6.8, 20% glycerol,
2% SDS, 5% β-mercaptoethanol, and 5% bromophenol blue) for 20 min. at room
temperature. Two 20-min. elutions with Lamelli buffer were typically required for
maximal elution of EAAT immunoreactivity. The extracts were then processed
for blot immunolabeling for EAAT as described above.

Total and Membrane-Associated Protein Data Analysis
All data were generated from individual rats.

Mean and SEM were

determined from each result obtained from the total number of rats used for each
study. One-way analysis of variance (ANOVA) was used to determine any agerelated changes in EAAT total and membrane-associated protein levels. We
used Tukey's post hoc tests to determine significance among groups if the
ANOVA results indicated a significant difference among the three age groups (p
< 0.05).

Drugs and Reagents
All chemicals were used as received unless otherwise stated.

Electrode Preparation and Calibration
Nafion (5% in a mixture of aliphatic alcohols and water), ascorbate, Lglutamate monosodium salt, and glutaraldehyde were obtained from SigmaAldrich. L-glutamate oxidase was purchased from Seikagaku America, Inc. 0.05
M phosphate buffered saline solution (PBS) was created using sodium chloride,
sodium phosphate monobasic, and sodium phosphate dibasic obtained from
Fisher Scientific (Fair Lawn, NJ).

Glutaraldehyde was stored at -20°C.

All

solutions were prepared using distilled water, which was de-ionized using a
Millipore water treatment system.
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Intracranial Pressure Ejection
All solutions administered intracranially were prepared in 0.09% saline
solution, adjusted to pH 7.4, and filtered prior to use through a sterile syringe
filter (0.22 µm pore size, Costar, Corning, NY). All components of the 70 mM
potassium (sodium chloride, potassium chloride, calcium chloride dihydrate) and
5 mM glutamate were purchased from Fisher Scientific.

Immunoblotting and Biotinylation
NHS-biotin and monomeric avidin beads were purchased from Pierce
Biotechnology (Rockford, IL). Protease inhibitors were obtained from Sigma. All
other solutions pertaining to biotinylation were purchased from Fisher Scientific
and Sigma unless otherwise stated.
Copyright © Justin Robert Nickell 2006
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Table 2.1 Distribution of Fischer 344 Rats Across Experimental Conditions
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Figure 2.2 Ceramic-Based Pt Microelectrode (R1 Configuration)
This geometrical configuration consists of four in-line recording sites, each
measuring 50 x 150 µm with 50 µm spacing between sites.
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Figure 2.3 Anesthetized In Vivo Glutamate Recording Apparatus
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Figure 2.4 Extracellular L-Glutamate Signal Parameters
Peak representative of a typical signal generated via application of 70 mM KCl
and 5 mM L-Glutamate solution. Please refer to text for detailed discussion of
these parameters.
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Figure 2.5 R1 Microelectrode Layer Schematic
Extracellular L-glutamate diffuses to the microelectrode surface, at which point it
contacts the glutamate oxidase layer.

Glutamate is metabolized to α-

ketoglutarate, a non-factor in the determination of synaptic glutamate, and H2O2,
which traverses the Nafion layer and is oxidized at the Pt recording site surface
at +0.7V vs. Ag/AgCl reference electrode. This process generates two electrons
per molecule of peroxide, thus the current produced is an indirect indication of
extracellular glutamate concentration.

Note that the Nafion layer excludes

potential negatively charged interferents via electrostatic repulsion.
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Chapter Three: Age-Related Changes in the Dynamics of PotassiumEvoked L-Glutamate Release in the Striatum of Fischer 344 Rats

Introduction
L-Glutamate is the primary excitatory neurotransmitter in the central
nervous system, and plays a primary role in a number of activities related to brain
plasticity including motor behavior, cognition, and memory. It is believed that
alterations in glutamate release and uptake dynamics are partially responsible for
the deficits in these functions that often occur with aging.

Prior studies of

glutamate release, however, are equivocal (Segovia et al., 2001b).

Some

studies have indicated that basal extracellular glutamate concentrations in the
hippocampus of aged (24 months) rodents may rise to levels 94% greater than
those found in young (6 months) animals (Freeman and Gibson, 1987).

By

contrast, more recent studies have attempted to show that these levels in aged
rodents may actually be 60% lower than in young animals (Saransaari and Oja,
1995).

Similarly, researchers have observed increases, decreases, or no

changes in basal extracellular glutamate levels in the aged striatum (Freeman
and Gibson, 1987; Massieu and Tapia, 1997; Corsi et al., 1997). Thus, it is
unclear why there are major discrepancies in the literature regarding the
regulation of glutamate release in aging.
Taken together, it may be that basal extracellular glutamate levels remain
constant throughout aging in rodents. However, these constant glutamate levels
are not necessarily indicative of static glutamate release and uptake processes.
Extracellular glutamate levels reflect a delicate balance between release and
uptake, meaning that age-related decreases in release may be compensated by
a regional decrease in uptake, and vice-versa (Segovia et al., 2001b).

It is

difficult, therefore, to accurately postulate mechanisms for the possible
alterations in glutamate dynamics as a result of aging, as prior studies using
brain slice methods and microdialysis techniques provide only a "snapshot" of
glutamate concentration at a particular time, and cannot differentiate between
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neuronal and glial sources of glutamate (Timmerman and Westerink, 1997).
Thus, they are limited in their capacity to provide us with the high temporal and
spatial resolution necessary for studying release of fast neurotransmitters such
as L-glutamate in the brain.
Contrasting data also exist for the phenomenon of glutamate clearance
from the synapse in the cerebral cortex and striatum. While most studies have
demonstrated a reduction in clearance of glutamate by astrocytes in aged
rodents (Wheeler and Ondo, 1986; Najerahim et al., 1990; Saransaari and Oja,
1995; Vatassery et al., 1998), other have reported no change (Dawson et al.,
1989; Palmer et al., 1994) or an increase in astrocyte clearance ability (Strong et
al., 1984). Once again, despite the discrepancies in data, there is a general
belief that aged rats have a lower uptake capacity for extracellular glutamate and
a decreased number of high affinity glutamate transporters in the striatum and
prefrontal cortex (Price et al., 1981; Wheeler and Ondo, 1986; Najerahim et al.,
1990; Vatassery et al., 1998; Saransaari and Oja, 1995). However, it is difficult
to interpret prior data, as researchers were limited in their ability to obtain a high
degree of temporal and spatial resolution regarding glutamate uptake.
In order to more rapidly measure L-glutamate release dynamics in vivo,
our laboratory has developed ceramic-based multisite microelectrodes for rapid
measures in the intact brain (Chapter Two). The enzyme-based microelectrode
has been developed and characterized for second-by-second measures of Lglutamate in the intact rat brain (Burmeister et al., 2000, 2002).

Phasic

glutamate release is produced in vivo by pressure ejection of a potassium
solution from a micropipette placed adjacent to the recording sites; the glutamate
released from nearby presynaptic terminals forms hydrogen peroxide by its
interaction with the glutamate oxidase coating on the microelectrode.

This

hydrogen peroxide is directly proportional to the L-glutamate concentration and
can be converted to extracellular L-glutamate levels by calibration.

This

technology allows us to accurately measure phasic changes of glutamate
concentrations within various brain regions on a second-by-second basis, while
maintaining a high degree of spatial resolution (microns) (Burmeister et al.,

33

2002).

The aim of this study was to utilize this technology to evaluate the

amplitudes and temporal dynamics of potassium-evoked L-glutamate release
and uptake in the young, late-middle aged, and aged F344 rat striatum.

In

addition, the heterogeneity of this brain region was characterized according to
the nature of its release and clearance properties throughout aging.

Materials and Methods
Please refer to Chapter Two for an in-depth discussion of all matters
pertaining to animal care, electrode preparation, generation of potassium-evoked
glutamate signals, and data analysis.

Results
Local applications of potassium for 1-2 seconds produced robust,
transient, and reproducible changes in extracellular levels of L-glutamate in the
striatum of the young, late-middle aged, and aged rats. The average L-glutamate
amplitudes were lower in both the late-middle aged (36.0 + 0.8 µM) and aged
rats (18.9 + 0.8 µM) when compared to the young animals (41.7 + 1.2 µM; both
p<0.001).

Thus, aging was seen to cause a robust decline in the maximal

amplitude of L-glutamate signals recorded in the striatum of the aged rats as
compared to young animals. In addition, a small but significant decline in the
release amplitudes was seen in the late-middle aged rats as compared to the
young rats (Fig. 3.2).
Due to the age-related changes in potassium-evoked L-glutamate signal
amplitudes, the L-glutamate release data were sub-divided into groups
composed of 10-20 µM signals from all age groups to study the temporal
dynamics of the signals in aging. When examining glutamate release dynamics,
the average volume of potassium necessary to evoke glutamate signals in the
range of 10-20 µM was greater (*p<0.05) in the 24 month rats (204 + 12 nl) than
in the young rats (169 + 8 nl). Likewise, the average amplitude of extracellular
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glutamate concentration achieved per nanoliter of potassium ejected was
attenuated in the 24 month rats (0.09 + 0.006 µM/nl) as compared to young
animals (0.15 + 0.007 µM/nl). Interestingly, signals from the striatum of latemiddle aged rats showed an increased response to potassium (0.21 + 0.01
µM/nl) in comparison to young rats (Figs. 3.1, 3.3).
Upon further examination of the data, L-glutamate uptake dynamics were
also compromised in the aged rats. When compared to young rats (3.9 + 0.08
µM/sec), the L-glutamate uptake rate in 24 month rats (3.1 + 0.10 µM/sec) was
significantly slower (***p<0.001) (Fig. 3.3).

Figure 3.2 illustrates this

phenomenon in much greater detail, as it compares the time dynamics of
individual signals representative of each of the three age groups. While the
release rate and total amplitude achieved were similar amongst the three age
groups, the time necessary for complete removal of glutamate from the
extracellular space in the 24 month rats was longer than in the 6 and 18 month
old animals.

Thus, the time dynamics of potassium-evoked release of L-

glutamate were seen to be altered in the aged rat striatum as compared to the
young and late-middle aged animals.
Depth-related alterations in potassium-evoked release and uptake in aging
were examined as well. The average uptake rate and amp/nl were calculated for
each depth (DV -3.0 to -7.0 mm, 0.5 mm increments) and compared amongst
age groups. This analysis yielded an abundance of data and highlighted many
age-related

significant

differences

in

glutamate

release

and

clearance

parameters. In consideration of space and clarity, please refer to Figures 3.4
and 3.5 for these results.

In terms of glutamate uptake rate, the significant

reduction in global clearance rate in the aged animals mirrored in the dorsal
regions of the striatum (DV -3.0 to -4.5 mm) was not present in the more ventral
depths of this structure (DV -5.0 to -6.5 mm). This disparity between age-related
local and global alterations of glutamate regulation became more apparent upon
analysis of corticostriatal projection excitability, as the global attenuation of
apparent fiber excitability in the aged animals was only observed in the dorsal
striatum (DV -3.0 to -4.5 mm), and the overall increase in excitability in the late-
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middle aged striatum was only found in the more ventral regions (DV -5.0 to -6.5
mm). Thus, global alterations in glutamate release and clearance in the striatum
are a reflection of a compilation of these parameter averages at all depths of the
structure.

Discussion
L-glutamate is a neurotransmitter of extreme value to normal CNS
functioning, and it possesses the capability to produce severe excitotoxic
damage. Therefore, it must be tightly regulated within the brain and in brain
areas such as the striatum. Our study indicates that while phasic release of Lglutamate is detectable in the aged rat, significant decreases in release
amplitudes and uptake rate occur in the aged rat brain. In the young animals,
potassium-evoked glutamate signals were robust and required smaller volumes
of potassium to achieve glutamate concentrations equal to those recorded in
aged rats. Late-middle aged rats had L-glutamate signals with larger amplitude
in response to the ejection of equivalent volumes of potassium when compared
to young rats.

In addition, the potassium effects on glutamate fibers were

diminished in aged rats, as there was a decrease in the apparent excitability in
comparison to young rats. Glutamate clearance was significantly compromised
in the aged striatum as well. This technology also permitted us to study depthrelated alterations in glutamate clearance and release in the layered striatum,
which highlighted that the majority of changes found at individual depths were
representative of the global alterations in these parameters. Thus, the present
studies employing the new ceramic-based microelectrodes for rapid measures of
L-glutamate support that there are significant age-related changes in phasic
glutamate release produced by local applications of potassium.
Previous studies of glutamate release and uptake in the aged rat striatum
are inconclusive.

While there are reports of reduced potassium-evoked

glutamate release that are in agreement with the results of our study (Freeman
and Gibson, 1987; Saransaari and Oja, 1995), there is an overwhelming number
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of studies supporting the idea that there is no net change in basal (Porras and
Mora, 1995; Saransaari and Oja, 1995; Corsi et al., 1999; Segovia et al., 1999)
or chemically induced (Donzanti et al., 1993; Sanchez-Prieto et al., 1994; Corsi
et al, 1997) extracellular glutamate concentrations. The data remain equivocal
on the issue of increased clearance rate (Strong et al., 1984), decreased
clearance rate (Wheeler and Ondo, 1986; Najerahim et al., 1990) or no change in
clearance rate of glutamate uptake in aging (Dawson et al., 1989).
We believe that this discrepancy in prior studies is due in part to the
limitations of the technique employed. Microdialysis is lacking in terms of the
high degree of temporal resolution necessary for studying neurotransmitters with
rapid release and uptake dynamics such as L-glutamate. In addition, this low
degree of temporal resolution increases the likelihood of detecting non-neuronal
glutamate; neuron-mediated glutamate release is rapid and is likely cleared from
the extracellular space in a matter of seconds. Over a time frame of several
minutes, the glutamate obtained in microdialysis experiments reflects glutamate
not only from neuronal stores, but from other sources as well. In fact, much of
this glutamate is not obtained via the fulfillment of classical release criteria, and
many researchers prefer to explain this phenomenon as being a result of
reversed-uptake by carrier-mediated processes. This has been shown to occur,
however, only in situations of excessive stimulation (Timmerman and Westerink,
1997).

Our ceramic-based microelectrodes provide the sub-second temporal

resolution necessary to give a more accurate representation of the dynamics of
phasic changes in extracellular L-glutamate. This allows us to better elucidate
the possible compensatory mechanisms responsible for maintaining static
extracellular glutamate concentrations in the rat striatum in young and aged rats.
Compensatory mechanisms are known to exist throughout the mammalian
CNS, and these may very well explain the striatum's ability to maintain relatively
stable basal glutamate concentrations during the aging process (Segovia et al.,
2001a). As demonstrated by Cobo et al. (1993), neurons in the prefrontal cortex
display a marked decrease in excitability in order to compensate for the loss of
glutamatergic neurons in the frontal cortex. In all, this results in no alteration in
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net basal glutamate levels. Our studies are in accordance with this notion of
decreased excitability, as corticostriatal glutamatergic nerve endings in aged rats
require a greater amount of potassium stimulation in order to reach the threshold
necessary for neurotransmitter release. Further studies are needed to determine
the mechanisms which may underlie this apparent change in excitability of Lglutamate synapses in the aged rat brain.
This decrease in apparent excitability of glutamate fibers may be guarding
striatal neurons from potential excitotoxic damage, as glutamate clearance rates
are significantly attenuated during aging. This carries with it several possible
interpretations. The first and most obvious hypothesis that could be drawn from
these data would be that there is either a down regulation of EAAT's or a
reduction in their efficiency.

Prior studies have confirmed that there is a

decrease in the maximal velocity of glutamate uptake in synaptosomes from
aged animals (Price et al., 1981; Wheeler and Ondo, 1986).

This would,

however, only account for the neurons' contribution to glutamate clearance,
which is relatively small in comparison to glial glutamate clearance (Danbolt,
2001), and no data, to the best of our knowledge, currently exist on glial
clearance rates in aged animals.
Regarding potential compensatory changes in aging, astrocytes have
been shown to increase in number and activity in the aged brain (Brizzee et al.,
1983; David et al., 1997).

This could very well offset a loss of neuronal

transporter efficiency. An increase in the number of transporters, however, does
not necessarily correlate with an increase in affinity (Segovia et al., 2001b), and
there have been few studies conducted on the glutamate affinity of these
transporters. Recent studies in our laboratory indicate a reduction in glutamate
clearance rates in aged animals (Chapter Four), which were associated with an
indication of increased numbers of transporters in the plasma membrane of glia
and/or neuronal synapses.

Clearly, additional studies are warranted to

determine the effect of aging on the functional dynamics of glutamate release
and uptake in the striatum and many other brain regions.
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The development of the microelectrode technology utilized in this study
has allowed us to obtain new insights into the temporal dynamics of potassiumevoked glutamate release and uptake in young and aged rat striatum.
particular

strength

of

this

technology

is

its

capability

to

A

investigate

neurotransmitter temporal dynamics in several depths of a layered structure such
as the striatum. The performance of such an assay is especially critical when
analyzing release and clearance in larger brain regions, as variance in the
density and release characteristics of neuronal projections then becomes a
potential confounding factor. The heterogeneity of the striatum has been well
characterized in a number of recent studies. Segovia et al. (1999) showed that
glutamate's facilitation of dopamine release was diminished in the ventral
striatum of middle-aged and aged rats, yet there was no significant loss of this
stimulatory effect during aging in the dorsal striatum. Marked changes were also
observed in neuronal activity in the ventral striatum in aged animals following the
administration of amphetamine or a D2 receptor antagonist, an effect that was not
present in the dorsal striatum (Crawford and Levine, 1997).

Moreover,

Friedemann and Gerhardt (1992) highlighted a dorsoventral gradient with respect
to the phenomenon of the amount of potassium stimulation necessary to evoke
dopamine release in the striatum.

Collectively, these data suggest that

dopaminergic and glutamatergic projections to the striatum are not uniform in
terms of distribution and/or excitability. In addition, our uptake assay indicates
that the clearance properties of glial and postsynaptic glutamate transporters
may change as a function of depth in aging animals as well. Therefore, when
attempting to investigate the temporal dynamics of transmitter release and
uptake in the striatum, it is necessary to analyze these parameters at many
depths of the structure and not simply infer that the data obtained from a single
layer are representative of the structure as a whole.
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Portions of this work have been published in the Journal of Neural Transmission:
Nickell, J., Pomerleau, F., Allen, J., Gerhardt, G.A. (2005) Age-related changes
in the dynamics of potassium-evoked L-glutamate release in the striatum of
Fischer 344 rats. J. Neural Transm. 112(1): 87-96.
Copyright © Justin Robert Nickell 2006
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Figure 3.1 Dose Dependency of Potassium-Evoked Glutamate Release
Representative tracings depicting the volume of potassium solution necessary to
elicit glutamate release of increasing amplitudes in both young (upper tracings)
and aged (lower tracings) F344 rats. Note the significant attenuation in response
in the aged animals upon application of similar volumes of potassium solution.
Potassium solution was applied at the time points indicated by arrows.
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Figure 3.2 Potassium-Evoked Glutamate Uptake Rate: Representative
Tracings
Series of recordings showing differences in amplitude-matched, potassiumevoked L-glutamate release dynamics in 6, 18 and 24 month old F344 rats. Note
the significantly slower uptake rate in the 24 month rats as compared to the 6
and 18 month old animals. Potassium solution was applied at the time points
indicated by the arrows.

The figure inset shows the decrease in average

maximum amplitude of potassium-evoked L-glutamate release that occurs in the
rat striatum in aging. ***p<0.001 vs. young animal group based on one-way
ANOVA

followed

by

Tukey's
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post-hoc

test.

Figure 3.3 Average Potassium-Evoked Glutamate Signal Parameters
Average values in the different age groups were for 1) comparison of L-glutamate
signal amplitudes, 2) volumes of potassium ejected, 3)L-Glutamate signal uptake
rates, and 4) maximal glutamate signal amplitudes obtained per nanoliter of
potassium ejected amongst the three age groups. Each bar represents mean +
SEM from seven animals in each age group. *p<0.05 and ***p<0.001 vs. young
animal group based on one-way ANOVA followed by Tukey's post-hoc tests.
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Figure 3.4 Depth-Related Alterations in Glutamate Uptake Rate in Aging
Glutamate uptake rates were calculated at several depths within each animal
(DV -3.0 to -7.0 mm) and compared amongst age groups. Note the that while the
dorsal striatum (DV -3.0 to -4.5 mm) exhibits a marked reduction in glutamate
clearance ability in the aged animals in comparison to young rats, no such
difference exists in the more ventral regions (DV -5.0 to -6.5 mm) of this
structure. Each bar represents mean + SEM from seven animals in each age
group.

***p<0.001 and **p<0.01 vs. young animal group based on one-way

ANOVA followed by Tukey's post-hoc tests.
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Figure 3.5 Depth-Related Alterations in Corticostriatal Excitability in Aging
Excitability of corticostriatal projections (amp/nl) was calculated at several depths
within each animal (DV -3.0 to -7.0 mm) and compared across age groups. A
reduction in the apparent excitability of corticostriatal fibers in aged animals was
only observed in the more dorsal striatum (DV -3.0 to -4.5 mm), while an
increase in excitability of these fibers in the late-middle aged rats was only found
in the ventral striatum (DV -5.0 to -6.5 mm). Above data are reported as mean +
SEM from seven animals in each age group. ***p<0.001, **p<0.01 and *p<0.05
vs. young animal group based on one-way ANOVA followed by Tukey's post-hoc
tests.
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Chapter Four: Reduced Plasma Membrane Surface Trafficking of GLAST
Mediates Decreased Glutamate Regulation in the Aged Striatum

Introduction
L-glutamate is the predominant excitatory amino acid neurotransmitter in
the mammalian CNS and plays a primary role in neural processes underlying
cognition, behavior, and motor functioning (Collindridge and Bliss, 1987; Cotman
et al., 1988; Mora and Cobo, 1990; Cobo and Mora, 1991; Schmidt et al., 1992).
While important for normal CNS functioning, deficits in extracellular glutamate
regulation pose a serious threat to the viability of surrounding neurons, as
elevated synaptic glutamate concentrations greatly increase the risk of
excitotoxic loss of neurons (Olney, 1969).

Glutamate dysregulation is also

believed to be a major player in aging, as the aged CNS is very susceptible to
excitotoxic insults from stroke or hypoxia (Liu et al., 1996; Brewer, 1998). Thus,
it is crucial that low extracellular glutamate levels be maintained via an efficient,
rapid, and robust transport mechanism (Balcar and Johnston, 1972; Logan and
Snyder, 1972; Johnston, 1981). To date, five sodium-dependent EAAT subtypes
have been cloned, and they act in concert as the exclusive means of terminating
glutamate neurotransmission (Pines et al., 1992; Storck et al., 1992). GLAST
and GLT-1 are located primarily on astrocytes, and account for approximately
ninety percent of all glutamate transport. Postsynaptically, EAAC1 is responsible
for removal of the remaining ten percent.

EAAT4 and EAAT5 have been

characterized in humans and have very specific localizations, the cerebellum and
retina, respectively, and so they are excluded from all discussions pertaining to
the cerebral cortex and deep structures of the rat brain (for review, see Danbolt,
2001).
Prior studies of aging in the striatum have not implicated these
transporters as having a significant contribution to alterations in glutamate
neurotransmission believed to play a role in age-related motor deficits and
increased secondary damage susceptibility.
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Further complicating matters, a

large portion of previous data pertaining to glutamate uptake are equivocal. For
example, Price et al. (1981) noted a decrease in glutamate uptake rate of 41%,
with a concurrent 32% increase in transporter affinity in aged rat synaptosome
preparations. In contrast, Strong et al. (1984) reported attenuation in transporter
affinity of 116%, with an accompanying increase in uptake rate of 84% in aged
animals. Furthermore, another study indicated no significant alteration in either
glutamate uptake rate or affinity in the aged rat model (Palmer et al., 1994).
We believe that these inconsistencies are due in large part to limitations of
the techniques employed; the analysis of glutamate release and clearance
dynamics requires a technique that provides a high degree of temporal resolution
(for review, see Segovia et al., 2001b; Timmerman and Westerink, 1997). We
recently used novel methodology to record glutamate release on a second-bysecond basis, which determined a reduction in glutamate uptake rate and a
concurrent decrease in the apparent excitability of glutamate fibers (Nickell et al.,
2005).

However, our prior study did not address the potential mechanisms

underlying the decrease in glutamate uptake rate. The present study aimed to
further explore this phenomenon by coupling in vivo electrochemical recordings
of glutamate uptake with classical immunoblotting and biotinylation in order to
determine the potential roles of total transporter protein levels and membrane
surface trafficking of these transporters in this apparent age-related decrease in
glutamate uptake rate. Collectively, the data support that changes in the surface
expression of GLAST may contribute to decreased regulation of extracellular
glutamate in the aged brain.

Materials and Methods
Please refer to Chapter Two for an extensive discussion of all methods
relating to the following research, including animal care, voltammetric recordings,
immunoblotting, and biotinylation.
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Results
A new recording approach was used to more directly investigate the
regulation of extracellular L-glutamate in vivo. Local applications of exogenous Lglutamate were used to directly investigate glutamate uptake and clearance time
in the striatum of young, late-middle aged and aged F344 rats. Rapid (1-2 sec.),
local ejections of nanoliter volumes of glutamate solution into regions of the
striatum produced robust, transient, and well-defined elevations in extracellular
glutamate concentrations, followed by a time period of rapid glutamate clearance
(see Figs. 4.1, 4.2). We investigated two ranges of signal amplitudes for our
temporal analyses of glutamate clearance, as our prior study (Nickell et al., 2005)
showed that the average maximal potassium-evoked release of glutamate in
young F344 animals was approximately 40 µM, while the average maximal
amplitude of potassium-evoked L-glutamate release in the aged rat striatum was
~20 µM. Therefore, glutamate signal amplitude ranges of 10-20 and 20-40 µM
were selected to simulate these two extracellular levels of L-glutamate clearance.
It must be noted that it is impractical to compare glutamate signals with vastly
differing amplitudes, as there is a direct correlation between synaptic glutamate
concentrations and clearance rates.

Thus, the rate of glutamate uptake

increases as extracellular levels of glutamate increase as seen in Figure 4.1.
The average extracellular glutamate concentration achieved with each
application among the three age groups in the 20-40 µM range was similar, as
there was no significant difference when comparing the young (30.10 + 0.17 µM),
late-middle aged (30.07 + 0.23 µM), and aged (29.57 + 0.20 µM) signal
amplitudes. Likewise, no differences existed among the three age groups when
comparing average signal amplitudes in the 10-20 µM range as well, as the
signals obtained in the young (15.88 + 0.15 µM), late-middle aged (15.88 + 0.20
µM) and aged (14.97 + 0.13 µM) rats did not vary much in amplitude (Fig. 4.3).
Our primary finding is that both the late-middle aged and the aged rat
brain display a compromised ability to remove extracellular L-glutamate, as
evidenced by clearance times using a parameter called T80. This measure is a
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calculation of the time necessary to clear 80% of the maximum signal amplitude,
and has proven to be an extremely reliable means to characterize clearance
efficiency in prior studies of both the dopamine (David et al., 1998) and serotonin
(Daws et al., 1998) systems of the brain.

Within the extracellular glutamate

amplitude range of 10-20 µM, T80 values in both the 18 (7.41 + 0.15 sec.; p<0.01)
and 24 month (8.85 + 0.29 sec.; p<0.001) rats were significantly prolonged in
comparison to those in the 6 month (6.00 + 0.11 sec.) animals. Likewise, T80
values for 20-40 µM signals obtained in young rats (6.10 + 0.07 sec.) were
significantly lower than those in the late-middle aged (7.80 + 0.10 sec.; p<0.001)
and aged (8.70 + 0.18 sec.; p<0.001) animals (see Fig. 4.3).
Upon further examination of these signals, the data also showed a
reduction in the rate at which the aged brain is capable of removing L-glutamate
from the extracellular space when examining both signal amplitude ranges. The
glutamate transporters in the young animals were significantly (p < 0.001) more
efficient (10.47 + 0.13 µM/sec.) in clearing glutamate in the 20-40 µM range than
those in the aged animals (8.25 + 0.20 µM/sec.). The clearance of glutamate
signals in the 10-20 µM range was also significantly (p<0.001) more rapid in the
young rats (4.62 + 0.10 µM/sec) than in the aged animals (2.70 + 0.10 µM/sec).
Interestingly, while there was no significant difference in glutamate uptake in the
late-middle aged striatum in comparison to the young animals in the 20-40 µM
amplitude range, glutamate clearance in these animals (5.08 + 0.16 µM/sec) in
the 10-20 µM range was significantly (p<0.01) faster than in the young or aged
groups.
Depth-related alterations in clearance time and uptake rate in aging were
examined as well. The average T80 and uptake rate were calculated at each
depth (DV -3.0 to -7.0 mm; 0.5 mm increments) and compared amongst age
groups. This analysis yielded an abundance of data and highlighted many agerelated significant differences in glutamate clearance ability. In consideration of
space and clarity, please refer to Figure 4.4 and Table 4.5 for these results.
Generally speaking, the relationship amongst age groups observed at dorsal
depths (DV -3.0 to -4.5 mm) paralleled the above reported global effects in terms
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of both uptake rate and clearance time. However, when examining clearance
times in more ventral regions of the striatum (DV -5.0 to -6.5 mm), the large
discrepancy in T80 amongst the age groups is greatly diminished. Thus, the aged
rat striatum displays a marked dorsoventral gradient in its ability to clear
glutamate from the extracellular space.
This age-related reduction in glutamate clearance time and uptake rate led
us to investigate the possibility that perhaps this phenomenon is due, in part, to
an attenuation in the production of total transporter protein. When comparing the
transporter responsible for the majority of glutamate clearance among the three
age groups, GLT-1, no significant difference was found (Fig. 4.6A). Likewise,
there was no difference in either GLAST or postsynaptic EAAC1 total protein
levels (Fig. 4.6B, C). Thus, we can state with confidence that the decreased
glutamate uptake rate we observe in aging is not due to reduced steady-state
levels of transporter proteins.
We continued to explore the potential mechanism underlying this
decreased clearance time and uptake rate by investigating relative plasma
membrane surface expression of the glutamate transporters via a biotinylation
technique. In order to process striatal homogenates for the assessment of all
three glutamate transporters from each animal, we determined expected signal
(as cpm from using I125-protein A for detection) from each transporter based upon
immunoreactivities given from each antibody and the aliquots used from each
step of preparation: P2 fraction, lysate (representing all protein), supernatant
from avidin bead spin (representing cytosolic protein), and two eluants from
treatment of avidin beads with Lamelli buffer (representing plasma membrane
protein). The relative immunoreactivities of the three transporter antibodies were
such that GLT-1 gave the strongest immunoreactivity per µg protein, followed by
GLAST, and then EAAC1. Aliquot volumes taken from each step were guided by
these immunoreactivities and in accordance with general handling as described
in previous studies (Salvatore et al., 2003; Gates et al., 2004; Zhu et al., 2005).
Each assayed amount was calculated for total amount based upon aliquot
volume, total volume of prepared sample, and total amount processed. In Figure
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5, the relative yields for each step in the processing of striatal tissue for
assessment of GLT-1 is shown. Briefly, a band of ~65-70 kDa was excised from
the blot and counted for gamma radioactivity.

Total recovery of GLT-1

immunoreactivities in the supernatant and eluant fractions was 73% of that
obtained from the lysate. Furthermore, assuming equal recovery of the GLT-1
from both fractions, the percent of GLT-1 associated with the eluant fraction was
~90% and that from the supernatant ~10%.

Therefore, it appears that the

majority of this glutamate transporter is expressed at the plasma membrane (Fig.
4.7).
No difference existed among the age groups when comparing GLT-1 and
EAAC1 in terms of membrane surface-association (Fig. 4.8B). However, when
comparing the surface expression of GLAST among the three age groups, there
was a significant reduction in surface expression in both the late-middle aged (42
+ 11 %; p < 0.05) and aged (55 + 13 %; p < 0.01) striatum in comparison to the
young animals (Fig. 4.8A).

Thus, a strong age-related decline in GLAST

membrane surface-association was observed that is in accordance with our
clearance time data.

Discussion
Regulation of L-glutamate signaling presents the mammalian CNS with an
interesting paradox. While a great majority of all excitatory neurotransmission in
the brain and spinal cord is mediated by glutamate (Fonnum, 1984; Orrego and
Villanueva,

1993),

slightly

elevated

extracellular

concentrations

of

this

neurotransmitter over a period of time establish a toxic environment for
surrounding neurons (Olney, 1969). As a result, maintenance of relatively low
synaptic glutamate levels is critical for cell survival and proper neuron
functioning. The current study investigated glutamate clearance alterations in
aging, as well as several potential mechanisms responsible for those changes.
When examining the clearance times of amplitude-matched applications of
exogenous glutamate, the data showed a significant decrease in clearance ability

51

in both the late-middle aged and aged rat striatum. This age-related decrease in
clearance ability was shown to demonstrate a marked dorsoventral gradient, as
clearance times were prolonged in the dorsal striatum in comparison to the
ventral striatum of the aged animals. We also provided evidence to conclusively
show that a potential alteration in total transporter protein levels in aging is not a
feasible mechanism to explain this phenomenon. Rather, it appears that an agerelated decrease in the membrane surface trafficking of GLAST is at least
partially responsible for this slowing of glutamate clearance in the aged brain.
Interestingly, the late-middle aged rat striatum exhibits a slightly increased
glutamate uptake rate in the 10-20 µM range despite a reduction in the glia
membrane surface expression of GLAST in the animals of this age group. A
recent study conducted by Salvatore et al. (2003) discovered a more rapid
dopamine clearance rate coupled with a reduction in the surface trafficking of the
dopamine transporter of nigrostriatal projections in late-middle aged rats in
comparison to young animals.

This finding validates the point that several

factors are responsible for determining the net uptake rate of glutamate; while
glutamate transporter steady-state protein levels and membrane expression are
critical components of this process, affinity of these transporters must also be
taken into consideration.

Therefore, the determination of the affinity of each

EAAT in the striatum of all age groups is necessary in the future in order to more
fully characterize the mechanism underlying impaired glutamate clearance, but
the lack of selective transporter inhibitors makes this difficult at this time. In
addition, clearance curves of injected substances are comprised of both diffusion
and transporter-mediated uptake processes (Cass et al., 1993), which further
complicate the interpretation of the rate data. We have previously determined
that the 80% decline times, or T80's, of clearance signals are extremely reliable to
characterize clearance of both the dopamine (David et al., 1998) and serotonin
(Daws et al., 1998) systems of the brain. In the present studies, the T80 values
were found to be highly reproducible and correlated with changes in the surface
expression of the glutamate transporters, analogous to the prior work of
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Salvatore et al. (2003).

Therefore, we believe that T80 is a more reliable

parameter for the study of the rapid temporal dynamics of glutamate clearance.
The marked dorsoventral gradient in clearance ability observed in the
aged striatum holds important implications for investigations of the motor
dysfunction that arises in senescence. Several studies conducted by Hebert and
Gerhardt (1998, 1999) discovered a compromised dopamine release capacity in
aged animals that was met with a concurrent reduction in dopamine clearance in
both the dorsal and ventral striatum.

This phenomenon is believed to be a

crucial compensatory mechanism for maintaining the normal synaptic lifespan of
dopamine in the aged brain. While these alterations were observed throughout
the striatum, our data indicate that glutamate uptake is compromised solely in the
dorsal striatum. Collectively, these data suggest that the primary motor circuitry
of the striatum located in the dorsal depths of the region incur a reduction in
glutamate clearance ability in order to sustain this transmitter's facilitation of
dopamine release in the aged basal ganglia. Additional studies are warranted to
further characterize the chronology and molecular underpinnings of such agerelated changes.
Emerging data have identified a number of molecules as potential factors
in the process of glutamate transporter regulation. These glial and postsynaptic
transporters share common putative protein phosphorylation sites in their primary
amino acid sequences (Kanai et al., 1993), leading many researchers (Pisano et
al., 1996; Casado et al., 1991; Sims and Robinson, 1999) to investigate the
possibility that EAAT regulation is mediated by protein kinases, notably protein
kinase C (PKC). Data have shown that activation of PKC in C6 glioma cells
rapidly increased cell surface expression of EAAC1 (Dowd and Robinson, 1996;
Davis et al., 1998) and similar results have been obtained in primary cultures of
neurons and astrocytes (Munir et al., 1997). However, these data are in stark
contrast with results obtained in alternate cell line models of other studies. For
example, EAAC1 activity and expression were decreased in Xenopus oocytes
(Trotti et al., 1998, 2001) cell lines, while GLT-1 membrane expression was
decreased in C6 glioma and primary cultures upon PKC activation (Kalandadze
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et al., 2000; Robinson, 2002). The equivocal nature of these studies continues
when examining the influence of PKC activation on GLAST membrane trafficking,
as researchers have noted increases, decreases, or no change in transporter
surface association following an increase in activated intracellular PKC levels
(Casado et al., 1991; Gonzalez and Ortega, 1997; Daniels and Vickroy, 1999;
Gonzalez et al., 1999).

Taken together, these data show that glutamate

transporter phosphorylation has differing effects that are dependent upon the
particular cell line utilized for study. Despite these inconsistencies, however,
these studies clearly demonstrate that alterations in glutamate transporter
membrane surface trafficking are a viable means whereby to regulate
extracellular glutamate levels in vivo as well as in vitro.
While the focus on glutamate transporter regulation continues to intensify,
scarce data, if any, are available on alterations of these transporters in aging. In
fact, a reduction in the density of NMDA receptors on the medium spiny neuron
postsynaptic membrane (Petersen and Cotman, 1989; Mitchell and Anderson,
1998) is the only finding that is without contention among researchers studying
aging in the striatum. Many prior studies have investigated the rate of glutamate
clearance in the striatum, and the results have led to the general conclusion that
glutamate uptake is compromised in the aged brain (for review, see Segovia et
al., 2001). However, one must use caution when interpreting these results, as
the technique used in these studies (microdialysis) does not possess the
necessary time resolution to completely study neurotransmitters with rapid
release and uptake dynamics such as glutamate (Timmerman and Westerink,
1997).

In addition, these data provide only indirect evidence of glutamate

transporter regulation (Segovia et al., 2001). To the best of our knowledge, our
study is the first to demonstrate that the decrease in glutamate clearance
efficiency observed in aging is due in part to a selective reduction in GLAST
membrane surface trafficking and not a reduction in total EAAT protein levels.
The results obtained in this study hold promising implications for the field
of aging research in the striatum. It has been well established that the aged
brain has an increased susceptibility to neurotoxic damage (Liu et al., 1996;
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Brewer, 1998), yet a reduction in the concentration of antioxidants has been the
only explanation offered for this phenomenon (Vatassery et al., 1998; Lynch,
1998).

Our data provide further insight to this increase in susceptibility by

examining the role of impaired glutamate transport and its potential contribution
to the establishment of a neurotoxic environment in aging (see Fig. 4.9). As we
have shown, the glia in the aged striatum exhibit a 55% reduction in the
trafficking of GLAST to the membrane surface, limiting its access to the
extracellular environment and subsequently reducing the rate at which glutamate
is cleared from the synapse.

Over time, this gradual elevation of tonic and

phasic glutamate concentration may result in increased NMDA receptor
stimulation, calcium and sodium influx, and reactive oxygen species (ROS)
production (Bondy and Lee, 1993; Lafon-Cazal et al., 1993; Reynolds and
Hastings, 1995; Savolainen et al., 1995). These elevated ROS levels could lead
to increased lipid peroxidation and glutamate transporter impairment via
peroxidation byproducts such as 4-hydroxynonenal (HNE) (Springer et al., 1997;
Pedersen et al., 1999; Keller et al., 1997; Blanc et al., 1998). In addition, energy
consumption of these medium spiny neurons may increase, as the ATP demand
placed on the pumps responsible for restoring ionic gradients will be greater
(Pellerin and Magistretti, 1994, 1997; Sibson et al., 1998; Novelli et al., 1988;
Kohmura et al., 1990). These are conditions that may be taxing to neurons over
a prolonged period of time and may contribute to increased age-related damage
of the CNS.
We conclude that the age-associated reduction in L-glutamate clearance
efficiency in the striatum of the aged F344 rat is partially due to decreased
membrane surface trafficking of GLAST. Altered glutamate transport has long
been implicated in the etiology of a number of neurodegenerative conditions in
humans, including amyotrophic lateral sclerosis (Rothstein et al, 1992, 1995; Lin
et al., 1998), episodic ataxia, seizures (Jen et al., 2005), and the age-related
Alzheimer's disease (AD) (Cross et al., 1987; Cowburn et al., 1988).
Researchers have more recently illustrated a strong relationship between AD and
GLAST expression. In transgenic mice with the London mutation (a mutation of
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familial AD), a reduction in GLAST expression in the neocortex was observed
(Masliah et al., 2000). Likewise, biochemical studies have discovered reduced
high-affinity L-glutamate uptake sites in cortex extracted from human brain tissue
(Cowburn et al., 1988; Cross et al., 1987; Scott et al., 1995). While a number of
these studies attributed the link between disease and transporter to decreased
GLAST

production,

more

recent

studies

acknowledged

that

internal

sequestration of transporters due to increased oxidative stress or amyloid betapeptide deposition could mask detection of a portion of the transporter pool from
specific antibodies (Zoia et al., 2005; Butterfield and Lauderback, 2002). Thus,
there is a strong possibility that decreased GLAST membrane-association may
play a role in AD etiology. Another potential causative factor in AD pertains to
the structure of the transporters themselves. According to Scott et al. (1995),
variant forms of GLAST are present in the cortex of Alzheimer's disease-afflicted
brains. Taken together, these alterations in GLAST may very well account for
much of the neurotoxic pathology observed in this age-related disease, as well
as the increased susceptibility to damage observed in ischemia and hypoxia.
Even so, these data were collected in brain regions other than the striatum, and
to the best of our knowledge no studies have been conducted in this region
concerning GLAST expression and its correlation with neurotoxic damage.
Clearly, additional studies are warranted to determine the role of GLAST in agerelated diseases and conditions in both animals and humans.
Copyright © Justin Robert Nickell 2006
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Figure 4.1 Glutamate Uptake Rate/Amplitude Correlation
Glutamate clearance signals in the rat striatum. Shown are representative
recordings illustrating the positive correlation between glutamate signal amplitude
and uptake rate. Tracings are comprised of signal amplitudes representative of
potassium-evoked glutamate release in the old (Amplitude: 16 µM, Uptake Rate:
4.38 µM/sec) and young (Amplitude: 35 µM, Uptake Rate: 13.5 µM/sec) F344 rat
striatum, as well as a signal representing glutamate release dynamics well
beyond the physiological range (Amplitude: 59 µM, Uptake Rate: 27.6 µM/sec).
Indicated on the left and right tracings are the portions of the decay curve
representing 80% glutamate clearance (T80), while the center tracing denotes the
portions of the signal utilized for calculation of uptake rate (maximum amplitude x
first order rate of the decay signal). The figure inset shows glutamate signal
amplitude versus uptake rate from signals recorded in a young animal (Pearson
correlation coefficient = 0.7186, ***p<0.001).
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Figure 4.2 Exogenous L-Glutamate Clearance: Representative Tracings
Series of L-glutamate voltammetric recordings showing differences in amplitude
matched L-glutamate clearance dynamics in 6, 18 and 24 month old F344 rats.
Note the significantly prolonged glutamate clearance time in the late-middle aged
and aged striatum in the left tracing, as well as the reduced glutamate uptake
rate in the signal on the right tracing corresponding to an aged rat. L-glutamate
solution was applied at the time points indicated by the arrows.
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Figure 4.3 Average Exogenous Glutamate Clearance Parameters
Average signal parameters from glutamate signals (10-20 and 20-40 µM)
recorded in the striatum of 6, 18 and 24 month old F344 rats. Average values in
the different age groups were for 1) comparison of L-glutamate signal amplitudes
and 2) the time necessary to clear 80% of exogenous glutamate in the striatum of
young, late-middle aged and aged rats. Each bar represents mean + SEM from
six, four and seven animals in 6, 18 and 24 month old rats, respectively.
***p<0.001 and **p<0.01 vs. young animal group based on nested betweengroups ANOVA followed by Tukey's post-hoc tests.
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Figure 4.4 Depth-Related Alterations in Glutamate Clearance Time (T80) in
the Striatum as a Function of Age
The average T80 for each depth (DV -3.0 to -7.0 mm; 0.5 mm increments) was
calculated and then compared amongst age groups. Note that while the average
T80 values of the young and late-middle aged animals display little variance
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amongst depths, the prolonged clearance time found in the dorsal striatum of the
aged rats is diminished as placement of the microelectrode proceeds in a ventral
direction. Each bar represents mean + SEM from six, four and seven animals in
6, 18 and 24 month old rats, respectively. ***p<0.001 and *p<0.05 vs. young
animal group based on nested between-groups ANOVA followed by Tukey's
post-hoc tests.
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Table 4.5 Depth-Related Alterations in Uptake Rate as a Function of Aging
The average uptake rates for each depth (DV -3.0 to -7.0 mm; 0.5 mm
increments) were calculated and then compared amongst age groups.
Glutamate uptake dynamics at most depths are representative of the structure as
a whole, the notable exception for both amplitude ranges being the most dorsal
depth studied (DV -6.0 to -6.5 mm). Data represent mean + SEM from six, four
and seven animals in 6, 18 and 24 month old rats, respectively. ***p<0.001 and
*p<0.05 vs. young animal group based on nested between-groups ANOVA
followed by Tukey's post-hoc tests.
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Figure 4.6 Striatal L-Glutamate Transporter Protein Levels as a Function of
Age
Western blots denoting striatal L-glutamate transporter total protein levels as a
function of aging. Numbers located below lanes for each transporter denote age
of animals in months. (A) Total GLT-1 levels per protein (cpm/µg; 30 µg per
lane) in the striatum across the three age groups analyzed. Data represent the
mean + SEM of values (n = 6). (B) Total GLAST levels per protein (cpm/µg; 15
µg per lane) in the striatum across the three age groups analyzed.

Data

represent the mean + SEM of values (n = 6). (C) Total EAAC1 levels per protein
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(cpm/µg; 60 µg per lane) in the striatum across the three age groups analyzed.
Data represent the mean + SEM of values (n = 6).
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Figure 4.7 Representative Biotinylation Assay
Western blot representing the relative immunoreactivities obtained from each
step of processing striatal homogenate for determining GLT-1 levels (~65-70 kDa
band) in each cellular fraction. For the P2 fraction, 15 µl of sample was loaded
from 225 µl of sample volume; for lysate, 15 µl of 225 µl; for supernatant
(representing cytosolic protein), 80 µl of 450 µl; for both eluants, 15 µl of 105 µl.
During processing of striatal homogenates, 100 µl of 300 µl of sample
(representing 500 µg of total protein) was set aside for lysate analysis. Therefore
the remaining 200 µl (representing ~330 µg protein) was processed for
assessment of cytosolic and plasma membrane levels. Sample volumes stated
above represent volumes from sample handling steps plus the addition of sample
buffer for electrophoresis. The remaining volume of sample from each step was
processed for analysis of GLAST and EAAC1. Numbers above bands represent
age group in months.
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Figure 4.8 Striatal Synaptosome Protein Recoveries in Plasma Membrane
(Bead Eluants) Fractions as a Function of Age
(A) Western blot illustrating GLAST immunoreactivities in avidin bead eluant
(representing plasma membrane fraction) from striatal synaptosomes from 6-,
18- and 24-month-old rats.

Relative GLAST-IR in the eluted fractions was

normalized to relative GLAST-IR for each age group in the lysates (representing
total GLAST prior to the addition of the avidin beads).

For each experiment, the

GLAST-IR in the 18- and 24-month-old fractions was compared against that in
the operationally matched 6-month-old fraction (n = 5 animals per age group).
Numbers located above lanes denote age group of animals in months. Data
presented in bar graphs represent mean + SEM from five animals in each age
group.

Asterisks indicate a significant difference as compared to 6 month

fractions (*p<0.05 and **p<0.01 vs. young animal group; Tukey's post-hoc test).
(B) Relative GLT-1 and EAAC1 immunoreactivity in the avidin bead eluant. The
GLT-1 and EAAC1 immunoreactivity in the 18- and 24-month-old fractions was
compared against that in the operationally matched 6-month-old fraction (n = 5
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animals per age group).

Data represent mean + SEM for all age groups.
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Figure 4.9 The Role of GLAST in Glutamate Dysregulation
Schematic of a young and aged striatal synapse illustrating the danger of a
dysregulation of extracellular L-glutamate.

Note that an identical number of

glutamate molecules are included in each diagram, and that an approximate 55%
reduction in plasma membrane-associated GLAST has occurred in the aged
schematic. As this decrease in GLAST surface expression becomes prevalent in
the aged striatum, extracellular L-glutamate concentrations become elevated, as
is evidenced by the concurrent reduction in clearance efficiency. This may lead
to increased ionotropic NMDA receptor stimulation and elevated intracellular
levels of Na+ and Ca2+ ions. This is potentially detrimental to neuron viability, as
this environment is conducive to the formation of increased levels of reactive
oxygen species and ATP consumption (see Chapter Four Discussion).
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Chapter Five: Investigations of Basal L-Glutamate Levels in the Aging
Striatum: An In vivo, Freely Moving Amperometric Study

Introduction
The strengths of the in vivo voltammetric technology employed in the
studies of the previous chapters are great in number; it provides us with the high
degree of spatial and temporal resolution necessary to study the rapid kinetics of
glutamate, while also providing us a means to characterize temporal release and
uptake dynamics as a function of regional depth. It must be noted, however, that
all previous applications of this technology were conducted in anesthetized
preparations, and the potential effects of anesthesia on glutamatergic
neurotransmission in the striatum have yet to be determined. The anesthetic of
choice for prior experiments, urethane, has been extensively studied in the
dopamine circuitry of the brain. The central nervous system depression imparted
by urethane is mediated by the interaction of this drug with a wide variety of
receptor classes, including glycine, GABA, NMDA, and AMPA receptors (Hara
and Harris, 2002), and while urethane may depress neuronal activity in dopamine
neuronal terminal fields, electrophysiological responsiveness to the indirect
dopamine agonist amphetamine remains unaltered (Warenycia and McKenzie,
1988). This, along with the finding that dopamine uptake remains consistent
following administration of urethane in the striatum of unrestrained rats (Sabeti et
al., 2003), suggests that urethane is an optimal anesthetic for non-survival
surgeries based on its minimal influence on dopaminergic motor circuitry. No
such studies, however, have been conducted to determine the potential effects of
this drug's interaction with glutamate receptors and transporters.
The inability to study age-related deficits in motor functioning in
anesthetized animals is another concern. In vivo electrophysiological studies
have provided great insight to dopaminergic motor neuron activity in aging.
Stanford and Gerhardt (2001a) demonstrated an age-related decrease in
amphetamine-induced firing rates of medium spiny neurons, as well as an
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increased pre-drug intraburst firing rate in the amphetamine-excited neurons in
the aged animals. This increased basal firing rate of the medium spiny neurons
has also been observed in other studies following the eradication of inhibitory
dopaminergic afferents via 6-hydroxydopamine lesions, and is believed to be due
in large part to the unchecked influence of glutamatergic corticostriatal
projections (Centonze et al., 1999; Herrling and Hull, 1980).

While these

experiments suggest that alterations in striatal glutamate dynamics may play a
substantial role in the motor dysfunction of aged animals, there has yet to be any
studies

conducted

to

observe

age-related

differences

in

glutamate

neurotransmission in awake young vs. aged rats. More recently, the multisite
microelectrodes utilized in the studies described in previous chapters have been
configured for in vivo recordings of extracellular glutamate, and they have reliably
detected alterations in glutamate concentrations upon repeated ejections of
exogenous L-glutamate in the behaving animal.

Whisker stimulation-induced

glutamate response in the striatum has been observed as well (Pomerleau et al.,
2003). While the current state of the technology lacks the capability to accurately
quantify the amount of drug ejected (< 1 µl) and characterize the heterogeneity of
glutamatergic terminals within the striatum, it is important to consider the possible
ramifications that anesthesia may have on glutamate signaling. Therefore, this
technology is extremely beneficial in examining the dynamics of corticostriatal
glutamate in the awake, behaving animal. This chapter chronicles the continual
development of the chronic implantation of ceramic-based microelectrode arrays
and their involvement in laying the foundation for future work correlating
alterations in glutamate neurotransmission in aging with behavior.

Materials and Methods

Microelectrode Design
The microelectrode recording site geometrical configuration selected for
these studies was the S2 electrode (Fig. 5.1). This configuration consists of four
15 x 333 µm recording sites arranged in a rectangular formation, 30 µm spacing
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between sites in an individual pair and a distance of 100 µm between pairs. This
particular recording site arrangement allows the investigator to employ a
technique known as "self-referencing", a method valuable for further validating
the purity and origin of all signals generated, that will now be discussed.

Microelectrode Selectivity
One issue that must be addressed in all experiments relying on the
specific detection and analysis of a single neurotransmitter of interest is that of
selectivity.

Currently, there are several techniques available to enhance the

selectivity of the microelectrode arrays for L-glutamate. The first method, as
discussed in Chapter Two, is the application of a layer of Nafion film which
serves to electrostatically repel negatively charged potential interferents such as
ascorbic acid. Varying the voltage applied to the Pt recording sites is another
useful tool in eliminating signal components which may be attributed to
interferents. By reducing the applied voltage from +0.7V to +0.2V, most peroxide
may no longer be oxidized at the surface of the electrode recording site.
Dopamine and other molecules, however, may still be detected at this voltage.
The discrepancy in signal between the two voltages can then be interpreted as
glutamate's contribution to the signal generated at +0.7V vs. Ag/AgCl reference
electrode.
A third method that was utilized for this study is self-referencing
(Burmeister and Gerhardt, 2001; Day et al., 2006). Figure 5.3 illustrates the
concept of this technique.

Briefly, the microelectrode recording site pair in

closest proximity to the ceramic tip was rendered sensitive to glutamate via the
normal addition of the glutamate oxidase/glutaraldehyde/BSA matrix as
described in Chapter Two. The remaining recording site pair was coated with an
inactive matrix of simply glutaraldehyde and BSA, resulting in sites nearly
identical to the other pair with the exception that these lack the capability to
detect glutamate.

Following the conclusion of each recording session, basal

glutamate levels were calculated as described below.
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Microelectrode Preparation
Microelectrodes utilized in freely moving recordings must undergo
extensive modification prior to implantation and the determination of basal
glutamate levels (Fig. 5.2). The initial step in converting the electrode to a stable
device for implantation is the addition of four 30 AWG varnished copper wires,
each corresponding to a single Pt recording site. Approximately 0.5 mm sections
of both ends of each wire were stripped prior to one end being soldered to a pinhole on the row nearest the microelectrode tip as depicted in Figure 5.2B. The
other end was soldered to a gold-plated socket amphenol (Ginder Scientific Part
#220-S02).

The microelectrode was then coated with five minute epoxy to

protect the connections from moisture damage for the remainder of the
procedure. All microelectrodes were then coated with Nafion and the glutamate
oxidase/BSA/glutaraldehyde matrix as previously described.
The final steps of the conversion process were conducted one day prior to
implantation.

All amphenols were firmly inserted into a miniature connector

(Ginder Scientific, 9-pin ABS Plug, Part #GS09PLG-220) with the aid of pliers so
that all amphenols were completely encased. A miniature Ag/AgCl reference
electrode was prepared and inserted in a similar fashion (Fig. 5.2C). All copper
wires were wrapped around the connector and the microelectrode positioned
parallel to the longitudinal axis of the connector.
administered

to

the

microelectrode/connector

Five minute epoxy was

apparatus

to

insulate

all

connections from moisture damage and to secure the microelectrode in position.

Microelectrode Calibration/Recording Apparatus
The recording of glutamate signaling in the awake, freely moving rat
dictates that the equipment utilized for anesthetized in vivo recordings be
modified in such a way as to allow for greater stability in the mobile animal.
Therefore, the recording setup for these experiments varies greatly from that
used to record in anesthetized rats. The headstage attaches directly to the rat
microelectrode assembly, connecting the chronically implanted microelectrode to
the FAST-16 recording system.

This headstage is comprised of a miniature
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connector with five connector pins designated for each of the four recording sites
and the Ag/AgCl reference electrode. The connector pins lead to a four channel
mini-amplifier positioned in close proximity to the animal in order to minimize
noise artifacts.

Shielded connecting wire leads to an electrical swivel

(commutator) at the ceiling of the recording chamber that contains twelve
electrical contacts. This configuration is optimal for allowing free rotation of the
headstage as the animal navigates the recording chamber.
In vitro calibrations were conducted as per the methods outlined in
Chapter Two (Fig. 5.4).

Microelectrode Implantation
Surgical implantation was conducted in its entirety in a Vertical Laminar
Flow Workstation (Microzone Corp., VLF-2-4). Animals were anesthetized with
sodium pentobarbital solution (50 mg/ml) administered in a single injection prior
to being placed in a stereotaxic frame.

All hair immediately surrounding the

surgical area was shaved, and an iodine solution was applied to the shaven area
in order to prevent potential infection. A 2 mm midline sagittal incision was made
and the skin reflected with bulldog clamps.

All underlying fascia was gently

displaced with a cotton swab, and the skull thoroughly cleaned with saline
solution to enhance the viewing of the skull sutures.
performed as described in Chapter Two.

A craniotomy was

Four additional holes (< 0.5 mm

diameter) were created for placement of the Ag/AgCl reference electrode and
three stainless steel skull screws (Small Parts Inc., Part #MPX-080-02-M). The
microelectrode/connector apparatus was implanted into the dorsal striatum (AP
+1.0mm, ML -2.5 mm, DV -5.0 mm; vs. bregma) based on coordinates provided
by the rat brain atlas of Paxinos and Watson (1986). The assembly was secured
with the addition of approximately four layers of Hygenic cold cure dental resin
(Island Dental Co., Inc., Catalog #844-0794) mixed with Jet Acrylic Liquid (Lang
Dental Manufacturing Co., Inc., Reference #1406) which adhered tightly to the
skull screws. This dental resin mixture covered the microelectrode/connector
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and all exposed wires, with great care taken to prevent resin from adhering to the
threads of the microelectrode connector.
Rats were permitted to recover on a heating pad (37ºC) to maintain body
temperature as the animals awakened from the anesthetic. Three subcutaneous
injections of 1 ml Ringer's Solution (Fisher Scientific, Catalog #S77939) were
administered subcutaneously to enhance recovery. All animals were allowed
three days to recover prior to the initial recording session.

Basal Glutamate Recording Sessions
Recording sessions were conducted on days four, five and six following
microelectrode implantation. All animals were allowed 20 minutes to acclimate to
the recording chamber prior to connecting them to the FAST-16 system.
Following the initiation of the recording software, approximately one hour was
necessary for all channels to attain a stable baseline reading, at which time data
relating to basal glutamate concentration were collected. At the conclusion of
each recording session (~2 hours), stress-evoked glutamate levels were
measured as well. A clothespin was placed at the base of the tail for a five
minute period, followed by a thirty minute stress-free time period in order to allow
glutamate concentrations to return to basal levels.

Data Analysis
Basal and stress-evoked glutamate levels were obtained and analyzed
from young (n = 7), late-middle aged (n = 6) and aged (n = 5) F344 rats. Basal
glutamate concentrations were obtained by averaging glutamate levels over a ten
second time period following the attainment of a stable baseline on channels
rendered sensitive to glutamate, and then subtracting concentrations obtained on
the accompanying self-referencing channel from this value. Due to the inherent
redundancy of each microelectrode, each self-referenced recording pair yielded
two striatal basal glutamate levels per day, per animal, resulting in a moderate
number of values for each age group.
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Data were analyzed via a one-way

analysis of variance (ANOVA) followed by a Tukey's post-hoc test. Statistical
significance was defined as p<0.05.

Results
The primary aim of these experiments was to validate the efficacy of the
ceramic-based microelectrode array as a useful tool to study aging in the
striatum of the freely moving F344 rat.

As illustrated in Figure 5.5, self-

referenced recording of basal glutamate in the striatum resulted in the production
of dual representative tracings at each electrode recording site pair. A simple
process of subtraction of these two values yielded average basal glutamate
concentration (see Materials and Methods). While the average basal glutamate
concentration of the late-middle aged striatum (6.27 + 2.15 µM) was reduced in
comparison to the young (7.20 + 1.19 µM) and aged (7.09 + 1.58 µM) animals,
no significant difference existed amongst the rats of all three age groups (Fig.
5.5).
An inherent advantage that this technology affords us is the capability to
further resolve these data to study alterations of basal glutamate levels within
age groups on several days. While no significant difference existed amongst
basal glutamate concentrations within age groups on the days selected for
recording sessions, this data analysis highlighted an interesting age-related
phenomenon. Basal levels of the young animals decreased slightly on day five
(4.74 + 1.51 µM) in comparison to the initial day of recording (5.30 + 1.54 µM),
yet basal glutamate concentration approximately doubled in magnitude on day
six post-implantation (9.58 + 2.38 µM). This phenomenon is also present in the
striatum of the aged animals, as basal glutamate levels on day four (6.50 + 0.82
µM) and five (6.15 + 1.31 µM) were similar, while concentration on day six (10.00
+ 3.48 µM) was much greater in magnitude. In addition to highlighting a potential
biological effect of a lack of acclimation to the recording process, this effect
confirms that the microelectrodes did not exhibit a reduction in sensitivity
throughout the three days selected for the recording sessions.
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This

phenomenon, however, is reversed in the late-middle aged rats. Basal glutamate
levels were elevated on the initial day of recording (9.19 + 3.86 µM) in relation to
both day five (2.75 + 2.12 µM) and six (3.94 + 0.26 µM) (Fig. 5.6).
Our data also demonstrate that the administration of a tail pinch stressor
to the animals results in a strong response in the glutamate circuitry of the
striatum. A typical bi-modal tail pinch stress response is depicted in Figure 5.7.
Upon the application of the stress, extracellular glutamate levels increased
rapidly to maximum amplitude (1-2 sec.) followed by a time of clearance and
sharp fluctuations in baseline that customarily spanned the duration of the tail
pinch stressor (Fig. 5.7).

Discussion
The utilization of ceramic-based microelectrode arrays for the study of
glutamate dynamics in anesthetized animals has proven to be a powerful tool in
prior aging research conducted in our laboratory. Several key issues regarding
the current state of the technique, however, must be addressed in order to
continue the evolution of this technology.

For instance, while the urethane

anesthetic selected for use in the non-survival surgeries described in Chapters
Three and Four has been demonstrated to exert minimal influence over certain
aspects of dopaminergic neurotransmission, emerging data within our laboratory
have shown that the administration of urethane to awake, freely moving F344
rats reduces basal glutamate levels in the striatum upwards of 40% (unpublished
observations).

In addition, previous electrophysiological data suggest that

alterations in the release and/or uptake properties of glutamatergic corticostriatal
projections may play a prominent role in the motor dysfunction observed in
normal aging (Stanford et al., 2001b), and the anesthetized animal preparation is
limited in terms of its capability to properly study this hypothesis.
The current study validates that the modification of our ceramic
microelectrodes for chronic implantation in the F344 rat is a feasible method
whereby to research alterations in glutamate neurotransmission in the aging
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striatum. Here we have demonstrated that, with the aid of self-referencing to
enhance the selectivity of the microelectrode, basal glutamate levels are not
significantly altered in either the late-middle aged or aged animals in comparison
to young rats. Also, while not significant, basal levels tend to rise as a function of
time in the young and aged animals, an effect that is reversed in the late-middle
aged rats. Finally, our data prove that the effects of a manual stressor may be
observed in the glutamatergic motor circuitry of striatum.
As mentioned previously, data obtained following the administration of
urethane to the freely moving F344 rat suggest that glutamate release and/or
uptake processes may indeed be impaired by this anesthetic.

A recent

investigation conducted by Day et al. (2006) that utilized the ceramic-based
multisite

microelectrode

array

technology

documented

throughout

this

dissertation validated this finding. Briefly, a basal glutamate level of ~2 µM in the
striatum of the young, anesthetized F344 rat was determined via a variety of
approaches, including the application of the universal glutamate transporter D,Lthreo-β-benzyloxyaspartate (TBOA) and implementation of the self-referencing
technique outlined within this chapter.

In addition, local application of

tetrodotoxin resulted in no significant alteration in basal glutamate levels,
indicating that the basal extracellular glutamate concentrations obtained in this
study were derived almost exclusively from neuronal origin.

These basal

glutamate levels are approximately one-third of the magnitude of those
calculated in the young, freely moving animal, thus further highlighting the
importance of eliminating the confounding variable of anesthetic when studying
basal glutamate release and clearance properties.
Many groups have recently attempted to investigate changes in glutamate
regulation in the freely moving rat via microdialysis. Once again, however, it is
crucial to consider the significant limitations imparted by this technique when
interpreting these data. Microdialysis provides the user with a high degree of
sensitivity (picomolar) and the ability to identify a number of analytes of interest,
yet it is particularly lacking in terms of temporal resolution. The typical sample
obtained by the performance of microdialysis is representative of analyte
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concentration over a period of several minutes, yet there have been significant
strides in recent studies to overcome this limitation; Kennedy et al. (2002)
coupled microdialysis on-line with capillary electrophoresis to attain a temporal
resolution of six seconds. Nonetheless, this study still lacks the subsecond time
resolution necessary to study the rapid dynamics of glutamate and has yet to be
conducted in an awake, freely moving animal.
Another important consideration when employing a technique that involves
chronic implantation and neurotransmitter sampling in the brain of an awake
animal is that of mechanical disruption and damage of surrounding neurons and
glia. An intricate study conducted by Clapp-Lilly et al. (1999) investigated this
phenomenon in the striatum of freely moving rats following microdialysis probe
placement. Briefly, light and electron microscopy were utilized to examine the
morphological

and

subcellular

characteristics

of

neurons

immediately

surrounding the area of implantation. Evidence of non-excitotoxic damage to
axons was found at the maximum distance observed from probe placement (1.4
mm), and an estimate of neuronal density revealed a significant loss in volume
up to a distance of 400 µm.

Cellular organelles such as mitochondria and

endoplasmic reticula also displayed swelling and bloating, characteristics of
necrosis-induced damage.

These processes may be significant confounding

factors in studies using microdialysis to study neurotransmitter release in freely
moving animals.
In comparison, chronically-implanted ceramic-based microelectrodes
induce minimal tissue damage in the striatum. Density of astrocytes surrounding
the microelectrode tract remains unaltered over a period of eight weeks, and the
number of activated microglia in the area are not significantly elevated
(unpublished observations).

Taken together, these observations indicate that

data collected using these microelectrode arrays may be more indicative of
normal physiological neurotransmitter release and clearance than those obtained
using more traditional methods of analysis such as microdialysis.
Nonetheless, a preponderance of all previous freely moving aging studies
have been conducted using microdialysis. Thus, we must interpret our results in
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light of these studies while keeping these technical limitations in mind.

Our

primary finding of no alteration in striatal basal glutamate levels in aging is in
accordance with the data obtained from a number of prior studies (Segovia et al.,
1999, 2001a; Del Arco et al., 2001). As discussed previously, glutamate release
in the striatum is not an isolated function, as corticostriatal projections receive a
high degree of modulation from adjacent dopaminergic projections. A recent
study by Segovia et al. (1999) examined this neurotransmitter interaction in the
context of aging in awake rats. Briefly, a universal glutamate uptake inhibitor, Ltrans-pyrrolidine-3,4-dicarboxylic acid (PDC), was perfused throughout the rat
striatum in varying concentrations to increase extracellular glutamate levels, and
the effects of these increased glutamate concentrations on dopamine release
were observed. It was discovered that while glutamate has a slightly elevated
ability to facilitate dopamine release in the middle-aged animals, there were no
significant alterations in glutamate-dependent dopamine release characteristics
in all age groups in comparison to young rats. This finding, coupled with data
that demonstrate no changes in basal dopamine levels in the aging striatum
(Segovia et al., 1999; Santiago et al., 1993; Kametani et al., 1995), suggests that
if dopamine's inhibitory influence on glutamate release remains unaltered in latemiddle aged and aged rats it is not beyond the realm of possibility that basal
glutamate levels remain consistent as well.
It is important to note that while both microdialysis and current
voltammetric freely moving studies remove the confounding factor of anesthetic,
they lack the capability to study basal glutamate concentration as a function of
depth. Due to the heterogeneous nature of the striatum as described in Chapters
Three and Four, it may be incorrect at this point in time to deem the basal
glutamate levels obtained in our study as representative of the entire striatum.
Rather, they are indicative of basal levels at a depth of five millimeters in the
dorsal striatum. There also remains the possibility that regional compensatory
mechanisms could temporarily mask reduced glutamate clearance or release at
this depth, resulting in no net alteration in basal glutamate levels (please refer to
Chapter Three for compensation discussion).
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Thus, it will be necessary to

investigate phasic glutamate release and clearance in the freely moving rat in
future studies.
Several key additions to the freely moving recording apparatus will make
such studies a possibility in the near future. To address the issue of the current
apparatus' inability to accurately eject minute volumes of solution (i.e. < 1 µl
potassium and glutamate) into the vicinity of the microelectrode, a fluid
commutator will be implemented.

The stationary nature of the current

microelectrode must also be remedied in order to better study the regional
aspects of glutamate regulation in the layered striatum.

This will be

accomplished following completion of the development of a microdrive that will
be compatible with the microelectrode/connector assembly and allow for
dorsal/ventral movement of the microelectrode within an animal.
These preliminary results have reliably shown that the modification and
implementation of ceramic-based microelectrodes for the study of basal
glutamate levels in the awake, freely moving animal is both practical and
necessary. The ultimate goal for this technology is to study glutamate temporal
release and uptake dynamics during the performance of a behavioral task
designed to examine motor efficiency.

There is strong electrophysiological

evidence implicating dysfunctional glutamate neurotransmission in age-related
motor deficiencies. Nonlocomotor-related striatal neurons were found to exhibit
increased firing rates and bursting activity during both bouts of locomotion and
periods of non-movement, suggesting that tonic hyperactivation of the
striatopallidal pathway of the basal ganglia may play a prominent role in the
bradykinesia observed in aged animals (Stanford and Gerhardt, 2004).

This

increased activity is believed to be due in large part to the unchecked release of
glutamate at the level of the medium spiny neuron, as both dopamine release
(Friedemann and Gerhardt, 1992; Kametani et al., 1995; Rose et al., 1986) and
the D2 receptors responsible for mediating their inhibitory action on glutamate
release are diminished in aging (Crawford and Levine, 1997; Han et al., 1989;
Hyttel, 1987). Clearly, additional studies are warranted to determine glutamate
release and uptake dynamics in the striatum of the freely moving, aged F344 rat.
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Figure 5.1 Ceramic-Based Pt Microelectrode (S2 Configuration)
This arrangement consists of four paired microelectrode recording sites in a
rectangular formation. Each recording site has dimensions of 15 x 333 µm, with
30 µm spacing between sites in a pair and a distance of 100 µm between pairs.
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Figure 5.2 Freely Moving Microelectrode Array Preparation
Series of photographs illustrating the various alterations necessary to convert an
S2 microelectrode to the lighter model utilized for freely moving recordings. A)
The printed circuit board and attached ceramic microelectrode tip.

Numbers

denote individual electrode recording site channels. B) Scored and cut circuit
board holder with galvanized copper wire soldered into each channel.

C)

Amphenols containing wires corresponding to each channel positioned in
connector.

D) Fully assembled connector/microelectrode array and freely

moving rat connector (top). The headstage circuit board is illustrated at center.
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Figure 5.3 Self-Referencing S2 Microelectrode Layer Schematic
Photomicrograph (center) of S2 microelectrode array and schematics (left, right)
describing preparation of electrode for self-referencing recordings. Recording
site pair depicted by (A.) are prepared as described in Figure 2.5, while the
remaining recording site pair (B.) is prepared in a similar fashion, the notable
exception being the lack of glutamate oxidase.

This technique provides the

investigator with another means to validate the purity of all signals obtained via a
method of subtraction.

Please refer to Materials and Methods for further

discussion.
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Figure 5.4 Sample Self-Referencing Microelectrode Calibration
Representative tracings illustrating the enhanced selectivity of self-referencing
microelectrodes. The black tracing represents a channel coated with Nafion and
the glutamate oxidase/glutaraldehyde/BSA mixture, while the blue tracing is
representative of a channel coated with simply the exclusion layer beneath the
glutaraldehyde/BSA mixture (sentinel channel). Note that while both channels
lack a response to the ascorbic acid interferent, only the channel rendered
sensitive to L-glutamate via the application of the enzyme layer responds to
subsequent additions of glutamate. The application of peroxide confirms that the
sentinel site's lack of response to glutamate is due to the absence of the enzyme
layer and not simply a malfunction of the microelectrode recording site.
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Figure 5.5 Basal Glutamate Recordings in the F344 Striatum in Aging
Sample striatal basal glutamate concentration recording from a young F344 rat
as a function of time. As described in the text, basal glutamate levels were
calculated by subtracting the average concentrations recorded on the sentinel
sites from those recorded on the glutamate oxidase-coated sites over a period of
ten seconds upon the attainment of a stable baseline. As a result, the disparity
between these values (as shown above) is a visual representation of the basal
glutamate concentration. The inset displays the average striatal basal glutamate
concentrations amongst the three age groups. All data represent mean (µM) +
SEM from seven young, six late-middle aged and five aged F344 rats.
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Figure 5.6 Time-Dependent Alterations in Basal Glutamate in Aging
Data representative of basal glutamate alterations over the course of the three
day recording sessions.

Note the sharp increase in basal glutamate

concentration on the final day of recording in both the young and aged animals,
while basal levels in the late-middle aged rats are reduced over time. All data
represent mean (µM) + SEM from seven young, six late-middle aged and five
aged F344 rats.
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Figure 5.7 Stress-Evoked L-Glutamate Release
Sample representative tracing of stress-evoked glutamate release upon the
application of a manual stressor. A clothespin was placed at the base of the tail
following the attainment of a stable baseline, resulting in a rapid and robust
increase (~80 µM) in extracellular glutamate concentration, followed by a period
of clearance from the synapse. Sharp fluctuations in basal glutamate are present
throughout the duration of the tail pinch stressor following the initial rise in
glutamate levels.
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